false 2025 --05-31 Q3 0001718500 0001718500 2024-06-01 2025-02-28 0001718500 2025-04-07 0001718500 2025-02-28 0001718500 2024-05-31 0001718500 2024-12-01 2025-02-28 0001718500 2023-12-01 2024-02-29 0001718500 2023-06-01 2024-02-29 0001718500 us-gaap:PreferredStockMember 2024-11-30 0001718500 us-gaap:CommonStockMember 2024-11-30 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0001718500 us-gaap:RetainedEarningsMember 2024-11-30 0001718500 2024-11-30 0001718500 us-gaap:PreferredStockMember 2023-11-30 0001718500 us-gaap:CommonStockMember 2023-11-30 0001718500 us-gaap:AdditionalPaidInCapitalMember 2023-11-30 0001718500 us-gaap:RetainedEarningsMember 2023-11-30 0001718500 2023-11-30 0001718500 us-gaap:PreferredStockMember 2024-05-31 0001718500 us-gaap:CommonStockMember 2024-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-05-31 0001718500 us-gaap:RetainedEarningsMember 2024-05-31 0001718500 us-gaap:PreferredStockMember 2023-05-31 0001718500 us-gaap:CommonStockMember 2023-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2023-05-31 0001718500 us-gaap:RetainedEarningsMember 2023-05-31 0001718500 2023-05-31 0001718500 us-gaap:PreferredStockMember 2024-12-01 2025-02-28 0001718500 us-gaap:CommonStockMember 2024-12-01 2025-02-28 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-12-01 2025-02-28 0001718500 us-gaap:RetainedEarningsMember 2024-12-01 2025-02-28 0001718500 us-gaap:PreferredStockMember 2023-12-01 2024-02-29 0001718500 us-gaap:CommonStockMember 2023-12-01 2024-02-29 0001718500 us-gaap:AdditionalPaidInCapitalMember 2023-12-01 2024-02-29 0001718500 us-gaap:RetainedEarningsMember 2023-12-01 2024-02-29 0001718500 us-gaap:PreferredStockMember 2024-06-01 2025-02-28 0001718500 us-gaap:CommonStockMember 2024-06-01 2025-02-28 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-06-01 2025-02-28 0001718500 us-gaap:RetainedEarningsMember 2024-06-01 2025-02-28 0001718500 us-gaap:PreferredStockMember 2023-06-01 2024-02-29 0001718500 us-gaap:CommonStockMember 2023-06-01 2024-02-29 0001718500 us-gaap:AdditionalPaidInCapitalMember 2023-06-01 2024-02-29 0001718500 us-gaap:RetainedEarningsMember 2023-06-01 2024-02-29 0001718500 us-gaap:PreferredStockMember 2025-02-28 0001718500 us-gaap:CommonStockMember 2025-02-28 0001718500 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001718500 us-gaap:RetainedEarningsMember 2025-02-28 0001718500 us-gaap:PreferredStockMember 2024-02-29 0001718500 us-gaap:CommonStockMember 2024-02-29 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001718500 us-gaap:RetainedEarningsMember 2024-02-29 0001718500 2024-02-29 0001718500 us-gaap:GeneralAndAdministrativeExpenseMember 2023-12-01 2024-02-29 0001718500 us-gaap:GeneralAndAdministrativeExpenseMember 2023-06-01 2024-02-29 0001718500 axil:CustomerMember 2024-12-01 2025-02-28 0001718500 axil:CustomerMember 2023-12-01 2024-02-29 0001718500 axil:CustomerMember 2024-06-01 2025-02-28 0001718500 axil:CustomerMember 2023-06-01 2024-02-29 0001718500 axil:PromotionalRisplayRacksMember 2025-02-28 0001718500 axil:PromotionalRisplayRacksMember 2024-05-31 0001718500 us-gaap:FurnitureAndFixturesMember 2025-02-28 0001718500 us-gaap:FurnitureAndFixturesMember 2024-05-31 0001718500 us-gaap:ComputerEquipmentMember 2025-02-28 0001718500 us-gaap:ComputerEquipmentMember 2024-05-31 0001718500 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentMember 2025-02-28 0001718500 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentMember 2025-02-28 0001718500 us-gaap:PropertyPlantAndEquipmentMember 2025-02-28 0001718500 us-gaap:PropertyPlantAndEquipmentMember 2024-05-31 0001718500 srt:MinimumMember us-gaap:OfficeEquipmentMember 2025-02-28 0001718500 srt:MaximumMember us-gaap:OfficeEquipmentMember 2025-02-28 0001718500 us-gaap:OfficeEquipmentMember 2025-02-28 0001718500 us-gaap:OfficeEquipmentMember 2024-05-31 0001718500 us-gaap:AutomobilesMember 2025-02-28 0001718500 us-gaap:AutomobilesMember 2024-05-31 0001718500 axil:LicensingRightsMember 2025-02-28 0001718500 axil:LicensingRightsMember 2024-05-31 0001718500 us-gaap:CustomerRelationshipsMember 2025-02-28 0001718500 us-gaap:CustomerRelationshipsMember 2024-05-31 0001718500 us-gaap:TradeNamesMember 2025-02-28 0001718500 us-gaap:TradeNamesMember 2024-05-31 0001718500 axil:WebsiteMember 2025-02-28 0001718500 axil:WebsiteMember 2024-05-31 0001718500 axil:ProductCertificationTestingMember 2025-02-28 0001718500 axil:ProductCertificationTestingMember 2024-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2020-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2020-05-01 2020-05-18 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2021-06-01 2022-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2024-12-01 2025-02-28 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2023-12-01 2024-02-29 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2025-02-28 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2024-06-01 2025-02-28 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2023-06-01 2024-02-29 0001718500 axil:EIDLMember 2025-02-28 0001718500 axil:EIDLMember 2024-05-31 0001718500 2022-06-01 2023-05-31 0001718500 us-gaap:PreferredStockMember 2024-03-01 2024-03-05 0001718500 us-gaap:PreferredStockMember 2024-06-01 2025-02-28 0001718500 us-gaap:CommonStockMember 2024-06-01 2025-02-28 0001718500 us-gaap:SeriesAPreferredStockMember 2025-03-01 2025-03-24 0001718500 axil:OneEmployeeMember 2025-01-02 0001718500 axil:OneEmployeeOneMember 2024-11-13 0001718500 axil:OfficersMember 2024-10-14 0001718500 axil:TwoConsultantsMember 2024-08-31 0001718500 axil:TwoConsultantsMember srt:MinimumMember 2024-08-31 0001718500 axil:TwoConsultantsMember srt:MaximumMember 2024-08-31 0001718500 axil:ThreeNonEmployeeDirectorsBoardMemberMember 2025-01-01 2025-01-13 0001718500 axil:ThreeNonEmployeeDirectorsBoardMemberMember 2024-02-02 2024-02-14 0001718500 axil:OneConsultantMember 2024-11-01 2024-11-13 0001718500 axil:RestrictedStockAwardsMember 2024-06-01 2025-02-28 0001718500 axil:RestrictedStockAwardsMember 2023-06-01 2024-02-29 0001718500 srt:MinimumMember 2024-06-01 2025-02-28 0001718500 srt:MaximumMember 2024-06-01 2025-02-28 0001718500 2023-06-01 2024-05-31 0001718500 axil:IntrepidMember 2024-06-01 2025-02-28 0001718500 axil:IntrepidMember 2025-02-28 0001718500 axil:IntrepidMember 2024-05-31 0001718500 axil:BZCapitalStrategiesMember 2024-06-01 2025-02-28 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2024-12-01 2025-02-28 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2023-12-01 2024-02-29 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2024-06-01 2025-02-28 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2023-06-01 2024-02-29 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:TwoCustomersMember 2024-06-01 2025-02-28 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsMember 2024-12-01 2025-02-28 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsOneMember 2024-12-01 2025-02-28 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsMember 2024-06-01 2025-02-28 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsOneMember 2024-06-01 2025-02-28 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsMember 2023-12-01 2024-02-29 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsOneMember 2023-12-01 2024-02-29 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsOneMember 2023-06-01 2024-02-29 0001718500 axil:HairCareAndSkinCareMember 2024-12-01 2025-02-28 0001718500 axil:HairCareAndSkinCareMember 2023-12-01 2024-02-29 0001718500 axil:HairCareAndSkinCareMember 2024-06-01 2025-02-28 0001718500 axil:HairCareAndSkinCareMember 2023-06-01 2024-02-29 0001718500 axil:HearingEnhancementAndProtectionMember 2024-12-01 2025-02-28 0001718500 axil:HearingEnhancementAndProtectionMember 2023-12-01 2024-02-29 0001718500 axil:HearingEnhancementAndProtectionMember 2024-06-01 2025-02-28 0001718500 axil:HearingEnhancementAndProtectionMember 2023-06-01 2024-02-29 0001718500 axil:HairCareAndSkinCareMember 2025-02-28 0001718500 axil:HairCareAndSkinCareMember 2024-02-29 0001718500 axil:HearingEnhancementAndProtectionMember 2025-02-28 0001718500 axil:HearingEnhancementAndProtectionMember 2024-02-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended February 28, 2025

 

OR

 

 TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to _____________

 

Commission File Number: 001-41958

 

 

AXIL Brands, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   47-4125218
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
9150 Wilshire Boulevard, Suite 245, Beverly Hills, California   90212
(Address of Principal Executive Offices)   (Zip Code)

 

(888) 638-8883

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   AXIL   The NYSE American LLC

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company 
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

As of April 7, 2025, there were 6,649,852 shares of the registrant’s common stock, $0.0001 par value, outstanding. 

 

 

   

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

 

INDEX

 

    Page
Cautionary Note Regarding Forward Looking Statements ii
   
PART I - FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited) 1
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 7
     
Item 4. Controls and Procedures 7
     
PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 8
     
Item 1A. Risk Factors 8
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 8
     
Item 3. Defaults Upon Senior Securities 8
     
Item 4. Mine Safety Disclosures 8
     
Item 5. Other Information 8
     
Item 6. Exhibits 9
     
Signatures 10

 

 -i- 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 

 

This Quarterly Report on Form 10-Q, and in particular Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding our assumptions about financial performance; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations, including expected growth, such as the proposed expansion of our offline retail presence and entry into international markets, and the potential divestiture of the Company’s hair and skin care business, which may not occur in a timely manner, or at all; and the economy in general or the future of the beauty and hair care industry and the hearing protection and ear bud business, all of which are subject to various risks and uncertainties.

 

There are a number of factors that could cause our actual results to differ from those indicated in the forward-looking statements, many of which are outside of our control. They include: the impact of unstable market and general economic conditions on our business, financial condition and stock price, including inflationary cost pressures, increased tariffs and other trade restrictions and barriers, interest rate changes, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, the possibility of an economic recession and other macroeconomic factors, geopolitical events and uncertainty, including the effects of the Ukraine-Russia conflict and conflict in the Middle East, and other downturns in the business cycle or the economy; our financial performance and liquidity, including our ability to successfully generate sufficient revenue to support our operations; our expectations regarding our financing arrangements and our ability to obtain additional capital if and as needed, including potential difficulties of obtaining financing due to market conditions resulting from geopolitical conditions and other economic factors; risks related to our operations and international markets, such as fluctuations in currency exchange rates, different regulatory environments, trade barriers and sanctions, exchange controls, and social and political instability; changes in the regulatory environment in which we operate, including environmental, health and safety regulations, including those related to climate change; our ability to protect and defend our intellectual property; continuity and security of information technology infrastructure and the potential impact of cybersecurity breaches or disruptions to our management information systems; widespread outages, interruptions or other failures of operational, communication, and other systems; competition; our ability to retain our management and employees and the potential impact of ongoing labor shortages; demands on management resources; availability and cost of the raw materials we use to manufacture our products, including the impacts of inflationary cost pressures, tariffs, and ongoing supply chain disruptions and constraints, which have been, and may continue to be, exacerbated by the Russia-Ukraine conflict, the conflict in the Middle East and other geopolitical conflicts; additional tax expenses or exposures; product liability claims; the potential outcome of any legal or regulatory proceedings, including ongoing litigation, the disposition of which may have an adverse effect upon our business, financial condition, or results of operations; our ability to engage in acquisitions, investments, partnerships, strategic alliances or dispositions when desired, including the potential divestiture of the Company’s hair and skin care business; global or regional catastrophic events, including the effects of natural disasters, which may be worsened by the impact of climate change; effectiveness of our marketing strategy, demand for and market acceptance of our products, as well as our ability to successfully anticipate consumer trends and to realize anticipated benefits from our efforts to expand into new geographic markets and product lines and into offline sales; labor relations; the potential impact of environmental, social and governance matters; implementation of environmental remediation matters; our ability to maintain effective internal control over financial reporting; and risks related to our common stock, including our ability to maintain our stock exchange listing.

 

When used in this Quarterly Report on Form 10-Q and other reports, statements, and information we have filed with the Securities and Exchange Commission (the “SEC”), in our press releases, presentations to securities analysts or investors, in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “may,” “can,” “will,” “expect,” “should,” “could,” “would,” “continue,” “anticipate,” “intend,” “likely,” “estimate,” “project,” “propose,” “plan,” “design,” “potential,” “focus” or similar expressions and variations thereof are intended to identify such forward-looking statements. However, any statements contained in this Quarterly Report on Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Furthermore, such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict.

 

We do not assume the obligation to update any forward-looking statement, except as required by applicable law. You should carefully evaluate such statements in light of factors described in this Quarterly Report on Form 10-Q. In this Quarterly Report on Form 10-Q, AXIL Brands, Inc. (“AXIL Brands, Inc.,” “AXIL,” the “Company,” “we,” “us,” and “our”) has identified material factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

 

 -ii- 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Financial Statements:  
   
Consolidated Balance Sheets - As of February 28, 2025 (Unaudited) and May 31, 2024 F-1
   
Consolidated Statements of Operations - For the three and nine months ended February 28, 2025 and February 29, 2024 (Unaudited) F-2
   
Consolidated Statements of Changes in Stockholders’ Equity - For the three and nine months ended February 28, 2025 and February 29, 2024 (Unaudited) F-3
   
Consolidated Statements of Cash Flows – For the nine months ended February 28, 2025 and February 29, 2024 (Unaudited) F-4
   
Condensed Notes to Unaudited Consolidated Financial Statements F-5

  

 -1- 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

           
   February 28, 2025   May 31, 2024 
   (Unaudited)     
ASSETS          
CURRENT ASSETS:          
Cash  $4,743,470   $3,253,876 
Accounts receivable, net   801,390    509,835 
Inventory, net   2,744,436    3,394,023 
Prepaid expenses and other current assets   961,876    809,126 
           
Total Current Assets   9,251,172    7,966,860 
           
OTHER ASSETS:          
Property and equipment, net   375,035    260,948 
Intangible assets, net   357,793    309,104 
Right of use asset   672,221    36,752 
Deferred tax asset   121,791    231,587 
Other assets   20,720    16,895 
Goodwill   2,152,215    2,152,215 
           
Total Other Assets   3,699,775    3,007,501 
           
TOTAL ASSETS  $12,950,947   $10,974,361 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
CURRENT LIABILITIES:          
Accounts payable  $896,365   $967,596 
Customer deposits   38,586    154,762 
Contract liabilities- current   786,834    905,311 
Notes payable   140,958    146,594 
Due to related party   28,576    11,798 
Lease liability, current   227,418    36,752 
Income tax liability   120,335    242,296 
Other current liabilities   210,679    332,936 
           
Total Current Liabilities   2,449,751    2,798,045 
           
LONG TERM LIABILITIES:          
Lease liability, long term   482,842    - 
Contract liabilities- long term   361,488    480,530 
           
Total long term liabilities   844,330    480,530 
           
Total Liabilities   3,294,081    3,278,575 
           
Commitments and contingencies (see Note 10)   -    - 
           
STOCKHOLDERS’ EQUITY:          
Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 27,773,500 and 42,251,750 shares issued and outstanding as of February 28, 2025 and May 31, 2024, respectively   2,777    4,225 
Common stock, $0.0001 par value: 450,000,000 shares authorized; 6,649,852 and 5,908,939 shares issued and outstanding as of February 28, 2025 and May 31, 2024, respectively   666    591 
Additional paid-in capital   8,687,130    7,825,240 
Retained Earnings/(Accumulated deficit)   966,293    (134,270)
           
Total Stockholders’ Equity   9,656,866    7,695,786 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $12,950,947   $10,974,361 

 

 

See accompanying notes to these unaudited consolidated financial statements.

 

 F-1 

 

  

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024

(UNAUDITED)

 

                     
   For the Three Months Ended   For the Nine Months Ended 
  

February 28,

2025
  

February 29,

2024
  

February 28,

2025
  

February 29,

2024
 
                 
Sales, net  $6,922,367   $6,469,343   $20,506,213   $20,997,289 
                     
Cost of sales   1,955,939    1,845,017    5,888,090    5,467,458 
Gross profit  $4,966,428   $4,624,326   $14,618,123   $15,529,831 
OPERATING EXPENSES:                    
Sales and marketing  $2,994,052   $3,398,949   $9,041,283   $10,278,570 
Compensation and related taxes   200,156    228,869    667,478    713,504 
Professional and consulting   796,689    687,138    2,480,707    1,990,426 
General and administrative   392,422    413,249    1,313,377    1,213,541 
                     
Total Operating Expenses  $4,383,319   $4,728,205   $13,502,845   $14,196,041 
INCOME (LOSS) FROM OPERATIONS  $583,109   $(103,879)  $1,115,278   $1,333,790 
                     
OTHER INCOME (EXPENSE):                    
Gain on settlement   -    -    -    79,182 
Other income   3,718    6,114    8,025    19,138 
Interest income   44,191    52,915    100,162    129,233 
Interest expense and other finance charges   (1,271)   (1,495)   (2,567)   (4,779)
                     
Other income (expense), net  $46,638   $57,534   $105,620   $222,774 
                     
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES  $629,747   $(46,345)  $1,220,898   $1,556,564 
                     
Provision (benefit) for income taxes   53,085   (827,436)   120,335    (397,054)
                     
NET INCOME  $576,662   $781,091   $1,100,563   $1,953,618 
                     
NET INCOME PER COMMON SHARE:                    
Basic  $0.09   $0.13   $0.17   $0.33 
Diluted  $0.07   $0.04   $0.13   $0.11 
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                    
Basic   6,516,852    5,863,939    6,373,502    5,863,939 
Diluted   8,202,402    18,576,914    8,196,605    18,569,140 

 

See accompanying notes to these unaudited consolidated financial statements.

 

 F-2 

 

  

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE AND NINE MONTHS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024

(UNAUDITED)

 

For the three months ended February 28, 2025

 

                                     
   Preferred Stock   Common Stock   Additional
Paid-in
    Retained   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital    Earnings   Equity 
Balance, November 30, 2024   31,133,500   $3,113    6,466,852   $647   $8,428,760    $389,631   $8,822,151 
                                     
Stock options expense   -    -    -    -    205,880     -    205,880 
                                     
Stock based compensation   -    -    15,000    3    52,170     -    52,173 
                                     
Preferred shares converted to common   (3,360,000)   (336)   168,000    16    320     -    - 
                                     
Net income for the three months ended February 28, 2025   -    -    -    -    -     576,662    576,662 
                                     
Balance, February 28, 2025   27,773,500   $2,777    6,649,852   $666   $8,687,130    $966,293   $9,656,866 

 

For the three months ended February 29, 2024

 

   Preferred Stock   Common Stock   Additional
Paid-in
    Retained Earnings/
(Accumulated
   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital    Deficit)   Equity 
Balance, November 30, 2023   250,000,000   $25,000    5,863,939   $586   $10,215,580    $(2,294,465)  $7,946,701 
                                     
Stock options expense   -    -    -    -    51,105     -    51,105 
                                     

Restricted stock awards

   -    -    15,000    2    7,992     -    7,994 
                                     
Net income for the three months ended February 29, 2024   -    -    -    -    -     781,091    781,091 
                                     
Balance, February 29, 2024   250,000,000   $25,000    5,878,939   $588   $10,274,677    $(1,513,374)  $8,786,891 

 

For the nine months ended February 28, 2025

 

                                    
   Preferred Stock   Common Stock  Issued/Issuable   Additional
Paid-in
   Retained Earnings/
(Accumulated
   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   Deficit)   Equity 
Balance, May 31, 2024   42,251,750   $4,225    5,908,939   $591   $7,825,240  - $(134,270)  $7,695,786 
                                    
Stock options expense   -    -    -    -    416,935    -    416,935 
                                    
Stock based compensation   -    -    17,000    3    443,579    -    443,582 
                                    
Preferred shares converted to common   (14,478,250)   (1,448)   723,913    72    1,376    -    - 
                                    
Net income for the nine months ended February 28, 2025   -    -    -    -    -  -  1,100,563    1,100,563 
                                    
Balance, February 28, 2025   27,773,500   $2,777    6,649,852   $666   $8,687,130  - $966,293   $9,656,866 

 

For the nine months ended February 29, 2024

 

   Preferred Stock   Common Stock   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance, May 31, 2023   250,000,000   $25,000    5,863,939   $586   $10,113,365  - $(3,466,992)  $6,671,959 
                                    
Stock options expense   -    -    -    -    153,320    -    153,320 
                                    

Restricted stock awards

   -    -    15,000    2    7,992    -    7,994 
                                    
Net income for the nine months ended February 29, 2024   -    -    -    -    -  -  1,953,618    1,953,618 
                                    
Balance, February 29, 2024   250,000,000   $25,000    5,878,939   $588   $10,274,677  - $(1,513,374)  $8,786,891 

 

See accompanying notes to these unaudited consolidated financial statements.

 

 F-3 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024

(UNAUDITED)

 

           
   For the Nine Months Ended 
   February 28, 2025   February 29, 2024 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net income  $1,100,563   $1,953,618 
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   93,001    83,634 
Provision for credit losses   31,834    143,395 
Reversal of inventory obsolescence   (23,448)   - 
Stock-based compensation   860,517    161,314 
Gain on forgiveness of account payable   (218,699)   - 
Gain on settlement   -    (79,182)
Deferred income taxes   109,796    (397,054)
Change in operating assets and liabilities:          
Accounts receivable   (323,389)   (445,883)
Inventory   673,034    (2,131,429)
Prepaid expenses and other current assets   (156,574)   145,032 
Accounts payable   147,472    1,061,420 
Other current liabilities   (322,358)   (144,052)
Contract liabilities   (237,519)   (11,490)
           
NET CASH PROVIDED BY OPERATING ACTIVITIES  1,734,230    339,323 
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of intangibles  (101,690)   - 
Purchase of property and equipment   (154,088)   (80,192)
           
NET CASH USED IN INVESTING ACTIVITIES  (255,778)   (80,192)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Repayment of equipment financing   -    (2,200)
Repayment of note payable   (5,636)   (25,438)
Advances from (payments to) a related party   16,778    (176,608)
           
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   11,142    (204,246)
           
NET INCREASE IN CASH   1,489,594    54,885 
           
CASH - Beginning of period   3,253,876    4,832,682 
           
CASH - End of period  $4,743,470   $4,887,567 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $2,567   $4,681 
Income taxes  $132,500   $- 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:          
Initial recognition of right of use assets recognized as lease liability  $767,269   $- 

 

See accompanying notes to these unaudited consolidated financial statements.

 

 F-4 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 1 – Organization

 

As part of AXIL Brands, Inc.’s (together with its subsidiary, the “Company,” “we,” “us” or “our”) ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company’s corporate headquarters are located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Its phone number is (888) 638-8883. In March 2022, the Company incorporated a subsidiary “Reviv3 Acquisition Corporation” (now known as “AXIL Distribution Company”) and in June 2022, completed the acquisition of certain assets of Axil & Associated Brands Corp. (“A&A”). The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality hair and skin care products. These product lines are both sold throughout the United States, Canada, Europe and Asia. On February 14, 2024, the Company successfully completed efforts to uplist from the over-the-counter, (OTC), markets to the NYSE American stock exchange (“NYSE American”).

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of February 28, 2025 and February 29, 2024, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended May 31, 2024. The results of operations for the three and nine months ended February 28, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

Reverse Stock Split

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20 as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

 

 F-5 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Use of estimates

 

The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S.”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash Common Stock issuances. 

 

Reclassifications

 

Certain reclassifications have been made to prior periods to conform with the current year reporting. For the three and nine months ended February 29, 2024, $134,216 and $519,401, respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited Consolidated Statements of Operations. There was no change to total operating expenses for the three and nine months ended February 29, 2024 as a result of this reclassification.

 

Cash and cash equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 12).

 

Accounts receivable and allowance for doubtful accounts

 

On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.

 

 F-6 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold. Prepayments to vendors for inventory was $468,903 and $472,904 as of February 28, 2025 and May 31, 2024, respectively.

 

Inventory

 

The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next 12 months is classified as non-current inventory.

 

Property and Equipment

 

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.

 

Product warranty

 

The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales. 

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.

 

 F-7 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Critical Accounting Policies (continued)

 

The Company sells a variety of electronic hearing and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.

 

The five steps for the revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories, and service performance obligations include extended warranty coverage.

 

However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.

 

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.

 

As of February 28, 2025, and May 31, 2024, contract liabilities amounted to $1,148,322 and $1,385,841, respectively. As of February 28, 2025, and May 31, 2024, contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $993,427 and $1,251,710, respectively; and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $150,818 and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three years. Approximately $348,088 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized in fiscal year 2026, and $104,356 in fiscal year 2027 and $172,728 in fiscal year 2028. Contract liabilities associated with gift cards purchased by customers amounted to $4,077 and $3,930, respectively as of February 28, 2025 and May 31, 2024.

 

 F-8 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Critical Accounting Policies (continued)

 

Cost of Sales

 

The primary components of cost of sales include the cost of the product and shipping fees related to product procurement.

 

Shipping and Handling Costs

 

The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses were $253,573 and $313,318 for the three months ended February 28, 2025 and February 29, 2024, respectively. Shipping costs included in marketing and selling expense were $768,625 and $807,333 for the nine months ended February 28, 2025 and February 29, 2024, respectively.

 

Sales, Marketing and Advertising

 

Sales, marketing and advertising costs are expensed as incurred.

 

Customer Deposits

 

Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy. 

 

Fair value measurements and fair value of financial instruments

 

The Company adopted ASC 820, “Fair Value Measurements and Disclosures,” for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: 

 

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
   
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
   
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

 

 F-9 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.

 

Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.

 

The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.

 

When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).

 

Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the carrying amount exceeds the fair value.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. 

 

 F-10 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Critical Accounting Policies (continued)

 

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

 

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service (“IRS”) and state taxing authorities, generally for three years after they are filed.

 

Impairment of long-lived assets  

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the three and nine months ended February 28, 2025 and February 29, 2024.

 

 F-11 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Critical Accounting Policies (continued)

 

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation,” which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

For non-employee stock option based awards, the Company follows Accounting Standards Update (“ASU”) 2018-7, which substantially aligns share based compensation for employees and non-employees.

 

Net income per share of Common Stock

 

Basic net income per share is computed by dividing the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. For the three and nine months ended February 28, 2025 and February 29, 2024, certain stock options, preferred shares and restricted stock awards were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income.

 

The dilutive common stock equivalent shares consist of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market price during the period.

 

The following table sets forth the computations of basic and diluted net income per common share:

 

                    
   For the Three Months Ended   For the Nine Months Ended 
   February 28,   February 29,   February 28,   February 29, 
   2025   2024   2025   2024 
                 
Net income  $576,662   $781,091   $1,100,563   $1,953,618 
                     
Weighted average basic shares   6,516,852    5,863,939    6,373,502    5,863,939 
Dilutive securities:                    
Convertible preferred stock   1,494,008    12,500,000    1,633,277    12,500,000 
Stock options   178,875    212,975    177,221    205,201 
Restricted stock awards   12,667    -    12,605    - 
Weighted average dilutive shares   8,202,402    18,576,914    8,196,605    18,569,140 
                     
Earnings per share:                    
Basic  $0.09   $0.13   $0.17   $0.33 
Diluted  $0.07   $0.04   $0.13   $0.11 

 

 F-12 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 2 – Basis of Presentation and Summary of Critical Accounting Policies (continued) 

 

Lease Accounting

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company’s consolidated financial statements.

 

The Company renewed its lease for its previous corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expired on December 1, 2024. The Company signed lease agreements in September 2024 for a warehouse along with a new lease for its corporate headquarters commencing October 1, 2024 and November 1, 2024, respectively. Please see Note 10 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.

 

Segment Reporting

 

The Company follows ASC 280, “Segment Reporting.” The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 13 – “Business Segment and Geographic Area Information” for more information about the Company’s reportable segments.

 

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form 10-K for the year ended May 31, 2025.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires entities to provide more detailed disaggregation of expenses in the income statement, focusing on the nature of the expenses rather than their function. The new disclosures will require entities to separately present expenses for significant line items, including but not limited to, depreciation, amortization, and employee compensation. Entities will also be required to provide a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, disclose the total amount of selling expenses and, in annual reporting periods, provide a definition of what constitutes selling expenses. This pronouncement is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements. 

  

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

 F-13 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 3 – Accounts Receivable, net

 

Accounts receivable, net consisted of the following:

 

          
   February 28, 2025   May 31, 2024 
Customers receivable  $776,313   $524,730 
Merchant processor receivable   117,156    78,417 
Less: Allowance for credit losses   (92,079)   (93,312)
Accounts receivables, net  $801,390   $509,835 

 

The Company recorded a provision for credit losses of $3,880 and $79,068 during the three months ended February 28, 2025 and February 29, 2024, respectively. The Company recorded a provision for credit losses of $31,834 and $143,395 during the nine months ended February 28, 2025 and February 29, 2024, respectively. 

 

Note 4 – Inventory, net

 

Inventory consisted of the following:

 

          
   February 28, 2025   May 31, 2024 
Finished Goods  $2,728,309   $3,190,344 
Raw Materials   16,127    203,679 
Inventory  $2,744,436   $3,394,023 

 

As of February 28, 2025 and May 31, 2024, inventory held at third party locations amounted to $322,012 and $58,242, respectively. As of February 28, 2025 and May 31, 2024, inventory in-transit amounted to $127,750 and $15,738, respectively. As of February 28, 2025 and May 31, 2024, the Company had provided $23,448 and $46,895, respectively, as obsolescence reserve on certain slow-moving inventory.

 

Note 5 – Property and Equipment

 

Property and equipment, stated at cost, consisted of the following: 

 

             
   Estimated Life  February 28, 2025   May 31, 2024 
Promotional display racks  2 years  $39,565   $30,709 
Furniture and Fixtures  5 years   67,653    5,759 
Computer Equipment  3 years   18,558    22,130 
Plant Equipment  5-10 years   351,078    264,168 
Office equipment  5-10 years   8,838    8,838 
Automobile  5 years   24,347    24,347 
Less: Accumulated Depreciation      (135,004)   (95,003)
Total Property, plant and equipment, net     $375,035   $260,948 

 

Depreciation expense amounted to $18,703 and $8,237 for the three months ended February 28, 2025 and February 29, 2024, respectively.  Depreciation expense amounted to $40,001 and $25,508 for the nine months ended February 28, 2025 and February 29, 2024, respectively. 

 

 F-14 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 6 – Intangible Assets

 

The intangible assets consisted of the following:

 

             
   Estimated Life  February 28, 2025   May 31, 2024 
Licensing Rights  3 years  $22,080   $34,024 
Customer Relationships  3 years   70,000    70,000 
Trade Names  10 years   275,000    275,000 
Website  5 years   100,000    100,000 
Product Certification Testing  3 years   101,690    - 
Less: Accumulated Amortization      (210,977)   (169,920)
Intangible assets, net     $357,793   $309,104 

 

Goodwill arising through the business combination in June 2022 was $2,152,215 at February 28, 2025.

 

Amortization expense amounted to $26,963 and $19,375 for the three months ended February 28, 2025 and February 29, 2024, respectively. Amortization expense amounted to $53,000 and $58,126 for the nine months ended February 28, 2025 and February 29, 2024, respectively. 

 

Note 7 – Other Current Liabilities

 

Other current liabilities comprised of the following:

 

          
   February 28, 2025   May 31, 2024 
Credit Cards  $245   $5,734 
Royalty Payment Accrual   -    3,376 
Sales Tax Payable   197,536    231,283 
Accrued expenses   12,898    92,543 
Total other current liabilities  $210,679   $332,936 

 

Note 8 – Notes Payable

 

During the year ended May 31, 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $150,000, which is administered under the authority and regulations of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the “EIDL”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The Loan, which is evidenced by a note dated May 18, 2020, bears interest at an annual rate of 3.75% and is payable in installments of principal and interest of $731 per month, beginning May 18, 2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively, “qualifying expenses”). The Company used the loan proceeds for qualifying expenses. During the year ended May 31, 2022, the Company received additional $10,000 of borrowings under the program. The Company received a loan forgiveness for $10,000 during the year ended May 31, 2022. The Company recorded interest expense, on the accompanying unaudited consolidated financial statements, of $1,271 and $1,495, during the three months ended February 28, 2025 and February 29, 2024, respectively and $2,567 and $4,779, during the nine months ended February 28, 2025 and February 29, 2024, respectively.

 

 F-15 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 8 – Notes Payable (continued)

 

As of February 28, 2025 and May 31, 2024, the outstanding balance of the loan amounted to $140,958 and $146,594, respectively.

 

The amounts of loan payments due in the next 12 months from February 28, 2025, are as follows:

 

        
   February 28, 2025   May 31, 2024 
Economic Injury Disaster Loan Program (EIDL)  $140,958   $146,594 

 

Note 9 – Stockholders’ Equity

 

Shares Authorized

 

As of February 28, 2025, the authorized capital of the Company consisted of 450,000,000 shares of common stock, par value $0.0001 per share and 300,000,000 shares of preferred stock, par value $0.0001 per share.

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not change the par value of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

 

Preferred Stock

 

The preferred stock may be issued from time to time in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited, or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.

 

During the fiscal year ended May 31, 2023, the Company issued 250,000,000 shares of non-voting Series A Preferred Stock, which, following the Reverse Stock Split of the Company’s common stock, are convertible into shares of the Company’s common stock on a twenty-to-one ratio. These 250,000,000 shares of non-voting Series A Preferred Stock were valued at the fair market value of $3,100,000 at issuance.

 

 F-16 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 9 – Stockholders’ Equity (continued)

 

The holders of shares of Series A Preferred Stock have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock. The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock into one fully paid and nonassessable share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.

 

The conversion provisions of the Company’s Series A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split, and the number of shares of Series A Preferred Stock issued and outstanding was not affected by the Reverse Stock Split.

 

On March 5, 2024, the Company entered into repurchase agreements with certain stockholders of the Company to purchase in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,490. Such repurchase was approved by the Company’s Board of Directors. Following the repurchase, 42,251,750 shares of Series A Preferred Stock remained outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the fiscal year 2024, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.

 

During the nine months ended February 28, 2025, certain stockholders of 14,478,250 preferred shares converted their preferred stock into 723,913 shares of common stock.

 

As of February 28, 2025 and May 31, 2024, 27,773,500 and 42,251,750 shares of Series A Preferred Stock, respectively, were issued and outstanding.

 

Effective March 24, 2025, the Company’s board of directors ratified certain past actions which provided that all shares of preferred stock that were repurchased by the Company along with those that were converted into shares of common stock would be considered retired. The Company retired 222,226,500 Series A preferred shares that were previously repurchased by the Company or converted into shares of common stock prior to such date.

 

Common Stock

 

As of February 28, 2025, 6,649,852 shares of common stock were issued and outstanding. 

 

See Preferred stock and Restricted Stock Awards and Restricted Shares Issued sections within this footnote for detailed discussions of common stock.

 

The Reverse Stock Split as more fully discussed in Note 2, did not change the par value of the common stock, modify any voting rights or other terms of the common stock, or change the number of authorized shares of the Company. Any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share.

 

 F-17 

 

  

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 9 – Stockholders’ Equity (continued)

  

Stock Options

 

Effective February 14, 2024, the Board amended the Company’s original 2022 Equity Incentive Plan (as amended the “Plan”), which was originally approved on March 21, 2022. The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors, non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i) Incentive Stock Options (to eligible employees only); (ii) Nonqualified Stock Options; (iii) Restricted Stock; (iv) Stock Awards; (v) Performance Shares; or (vi) any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March 21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend or terminate the Plan without stockholder approval, subject to certain exceptions.

 

On October 8, 2024, the Board of Directors approved the amendment and restatement of the Plan in order to increase the number of shares authorized for issuance under the Plan by 800,000 shares, any or all of which may be issued pursuant to grants of “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code). The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.

 

The total number of shares initially authorized for issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option, or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued shares.

 

Two types of options may be granted under the Plan: (1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of the option not less than the fair market value of the common stock on the grant date, or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110% of the fair market value of the common stock on the grant date; and (2) Non-qualified Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value of the common stock on the grant date, but not less than par value of the stock.

 

The Board may grant or sell restricted stock to participants (i.e., shares that are subject to a subject to restrictions or limitations as to the participant’s ability to sell, transfer, pledge or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.

 

Each equity-based award granted under the Plan will be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the Board may determine, consistent with the provisions of the Plan.

 

 F-18 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 9 – Stockholders’ Equity (continued)

 

Subject to the Plan’s terms, the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.

 

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

 

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

 

On January 2, 2025, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on December 31, 2034. The options vest quarterly over a year beginning on March 1, 2025.

 

On November 13, 2024, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.

 

On October 14, 2024, the Company issued to two Company officers stock options to purchase, in the aggregate, up to 600,000 shares of its common stock, at an exercise price of $4.01 per share valued at $2,406,000 and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments starting on the grant date.

 

During the three months ended August 31, 2024, the Company issued stock options, to two consultants, to purchase, in the aggregate, up to 24,000 shares of its common stock, at an exercise price equal to the Company’s closing price on the NYSE American on the date of grant which ranged from $5.94-$10.39. The options are valued at approximately $195,960 and expire in ten years from the date of grant.

 

 F-19 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 9 – Stockholders’ Equity (continued)

 

The following table presents the range of assumptions used to estimate the fair value of the stock options granted during the nine months ended February 28, 2025:

 

   
    February 28, 2025
Risk free interest rate   3.84% - 4.43
Expected life   5 - 7 years
Expected volatility   458% - 467%
Expected dividend   -

 

The following table summarizes the activities for the Company’s stock option activity for the nine months ended February 28, 2025:

 

               
   Number of
Options
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Term
 
Outstanding as of May 31, 2024   268,750   $1.84    7.9 
Granted   634,000    4.17      
Exercised/Forfeited   -    -      
Less: Unvested at February 28, 2025   (571,000)   4.09    6.1 
Vested at February 28, 2025   331,750   $2.42    7.6 

 

During the nine months ended February 28, 2025, the Company expensed $416,935 with respect to options, of which $280,584 was included in General and administrative, and $136,352 in Sales and marketing, respectively, in the accompanying Consolidated Statements of Operations. During the nine months ended February 29, 2024, the Company expensed $153,320 with respect to stock options, which was included in General and administrative in the accompanying Consolidated Statements of Operations.

 

Restricted Stock Awards and Restricted Shares Issued

 

The Company’s non-employee directors participate in the Company’s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan, on January 13, 2025, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $62,250.

 

Effective February 14, 2024, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $195,000.

 

Effective May 28, 2024, a former officer entered into a Separation Agreement and Release (the “Release”), which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting Agreement, dated May 28, 2024, with the former officer (the “Consulting Agreement”), pursuant to which the former officer agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted common stock valued at $298,800, which vested upon grant.

 

Effective November 13, 2024, the Company issued 2,000 shares of restricted common stock to a consultant for services relating to expansion of the Company into new markets. The shares were valued at $8,000 based on the Company’s closing price on the NYSE American on the date of grant. The shares vested upon grant and will be expensed over the six month service period of the consultant beginning from the grant date.

 

The fair value of the stock grants is being recorded over the term of the service related to each grant. During the nine months ended February 28, 2025, the Company expensed $443,582 related to restricted stock awards and restricted stock expense, of which $438,892 was included in General and administrative in the accompanying Consolidated Statements of Operations, and $4,690 in Sales and marketing, in the accompanying Consolidated Statements of Operations. During the nine months ended February 29, 2024, the Company expensed $7,994 related to restricted stock awards and restricted stock expense.

 

 F-20 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 10 – Commitments and Contingencies

 

Leases

 

The Company treats a contract as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or if the Company directs the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (“ROU”) assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company’s right to use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company’s obligation to make payments over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease. In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, the Company applies a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For variable costs that may change during the lifetime of the lease, the Company expenses as incurred. Since the interest rate implicit in a lease is generally not readily determinable for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease term to obtain an asset of similar value.

 

The Company reviews the impairment of ROU assets consistent with the approach applied for the Company’s other long-lived assets. The Company reviews the recoverability of long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations.

 

Lease expense is recognized on a straight-line basis over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities.

 

During the nine months ended February 28, 2025, the Company entered into two new lease agreements. The Company’s lease agreements do not contain any residual value guarantees or restrictive covenants. The Company’s lease agreements do not have an explicit renewal option, and the termination options are available in the event of material breaches. The expiration dates of the leases are on September 30, 2027 and January 31, 2029.

 

The Company computed an initial lease liability of $767,269 for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement of the leases. During the three months ended February 28, 2025 and February 29, 2024, the Company recorded operating lease costs in the amount of $66,108 and $18,659, respectively. During the nine months ended February 28, 2025 and February 29, 2024, the Company recorded operating lease costs in the amount of $133,847 and $55,976, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses on the accompanying Consolidated Statements of Operations. 

 

The weighted average remaining term and discount rate for the Company’s operating leases as of February 28, 2025 was 3.6 years and 13.0%, respectively.

 

 F-21 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 10 – Commitments and Contingencies (continued)

 

Supplemental balance sheet information related to leases was as follows:

 

          
Assets  February 28, 2025   May 31, 2024 
Right of use assets  $899,239   $131,970 
Accumulated reduction   (227,018)   (95,218)
Operating lease assets, net  $672,221   $36,752 
           
Liabilities          
Lease liability  $899,239   $131,970 
Accumulated reduction   (188,979)   (95,218)
Total lease liability, net   710,260    36,752 
Current portion   (227,418)   (36,752)
Non-current portion  $482,842   $- 

 

Maturities of operating lease liabilities were as follows as of February 28, 2025:

 

     
Operating Lease (fiscal year-end)    
2025 (three months remaining)  $65,675 
2026   258,005 
2027   269,437 
2028   218,420 
2029   128,040 
Total  $939,577 
Less: Imputed interest   (229,317)
Present value of lease liabilities  $710,260 

 

Accounts Payable

 

During the nine months ended February 28, 2025, the Company renewed its relationship with an entity, and as a result of the agreement, $218,699 previously due in relation to royalties, was forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations.

 

Contingencies

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

 F-22 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 11 – Related Party Transactions

 

The Company’s Chairman and Chief Executive Officer (“CEO”), Jeff Toghraie, is the managing director of Intrepid Global Advisors (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the year. Intrepid was paid approximately $178,000 in consulting fees for the nine months ended February 28, 2025. As of February 28, 2025 and May 31, 2024, the Company had amounts payable to Intrepid of $28,576 and $11,798, respectively. These advances were short-term in nature and non-interest bearing. The Company’s Board Member, Chief Financial Officer ("CFO"), and Chief Operating Officer ("COO") has a controlling interest in BZ Capital Strategies. BZ Capital Strategies was paid $100,000 in consulting fees for the nine months ended February 28, 2025.

 

Note 12 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents instruments. The Company maintains its cash in bank deposits accounts. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At February 28, 2025 and May 31, 2024, the Company held cash of approximately $3,993,470 and $3,003,876, respectively, in excess of federally insured limits. The Company has not experienced any losses in such accounts through February 28, 2025.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier

 

The Company predominantly sells the products direct-to-consumer. There was no single customer that accounted for greater than 10% of consolidated net sales for the three and nine months ended February 28, 2025 and February 29, 2024.

 

During the three months ended February 28, 2025, approximately 92.8% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). During the three months ended February 29, 2024, approximately 96.1% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). All Company assets are located in the U.S.

 

During the nine months ended February 28, 2025, approximately 91.1% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). During the nine months ended February 29, 2024, approximately 93.9% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address).

 

As of February 28, 2025, accounts receivable from customers that accounted for more than 10% of sales transactions were from two customers amounting to 38.9%. As of May 31, 2024, no single customer accounted for more than 10% of accounts receivable.

 

Manufacturing is outsourced primarily overseas via a number of third-party vendors. The two largest vendors accounted for 68.3% and 26.2%, respectively, of all purchases for the three months ended February 28, 2025. For the nine months ended February 28, 2025, the two largest manufacturing vendors accounted for  65.1% and 26.5%, respectively. For the three months ended February 29, 2024, the two largest manufacturing vendors accounted for 76.0% and 12.2%, respectively. For the nine months ended February 29, 2024, one vendor accounted for 84.8% for all inventory purchases.

 

 F-23 

 

   

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 13 – Business Segment and Geographic Area Information

 

Business Segments

 

The Company, directly or through its subsidiaries, markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing enhancement and hearing protection business. The Company’s determination of its reportable segments is based on how its chief operating decision makers manage the business. 

  

The Company’s segment information is as follows:

 

                    
  Three months ended   Nine months ended 
   February 28, 2025   February 29, 2024   February 28, 2025   February 29, 2024 
Sales, net                    
Hair care and skin care  $472,302   $476,864   $1,308,356   $1,022,458 
Hearing enhancement and protection   6,450,065    5,992,479    19,197,857    19,974,831 
Total net sales  $6,922,367   $6,469,343   $20,506,213   $20,997,289 
                     
Operating earnings (loss)                    
Segment gross profit:                    
Hair care and skin care  $255,968   $247,859   $685,964   $641,966 
Hearing enhancement and protection   4,710,460    4,376,467    13,932,159    14,887,865 
Total segment gross profit   4,966,428    4,624,326    14,618,123    15,529,831 
Selling and Marketing   2,994,052    3,398,949    9,041,283    10,278,570 
General and Administrative   1,389,267    1,329,256    4,461,562    3,917,471 
Consolidated operating income (loss)  $583,109   $(103,879  $1,115,278   $1,333,790 
                     
Total Assets:                    
Hair care and skin care  $4,647,830   $4,232,913   $4,647,830   $4,232,913 
Hearing enhancement and protection   8,303,317    8,480,805    8,303,317    8,480,805 
Consolidated total assets  $12,950,947   $12,713,718   $12,950,947   $12,713,718 
                     
Payments for property and equipment and intangible assets                    
Hair care and skin care  $1,870   $-   $1,870   $- 
Hearing enhancement and protection   146,285    9,347    253,908    80,192 
Consolidated total payments for property and equipment and intangible assets  $148,155   $9,347   $255,778   $80,192 
                     
Depreciation and amortization                    
Hair care and skin care  $932   $1,417   $2,610   $4,251 
Hearing enhancement and protection   44,734    26,197    90,391    79,383 
Consolidated total depreciation and amortization  $45,666   $27,614   $93,001   $83,634 

 

Geographic Area Information

 

For geographic area information of sales for the three and nine months ended February 28, 2025 see Note 12 – Concentrations.

  

 F-24 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONDENSED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

FEBRUARY 28, 2025

 

Note 14 – Income Taxes

 

We calculated our interim tax provision in accordance with ASC 270, “Interim Reporting,” and ASC 740, “Accounting for Income Taxes.” As the end of each interim quarterly period, we estimate our annual effective tax rate and apply that rate to our ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects of other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.

 

We recorded an income tax expense of $53,085 for the three months ended February 28, 2025 and an income tax benefit of $827,436 for the three months ended February 29, 2024. We recorded an income tax expense of $120,335 for the nine months ended February 28, 2025 and an income tax benefit of $397,054 for the nine months ended February 29, 2024.

 

The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company’s 2021, 2022, 2023 and 2024 Corporate Income Tax Returns are subject to IRS examination.  

 

 F-25 

 

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with, and is qualified in its entirety by, the unaudited consolidated financial statements and related notes thereto included in Item 1 in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended May 31, 2024 filed with the SEC on August 15, 2024. Our Management’s Discussion and Analysis of Financial Condition and Results of Operations contains not only statements that are historical facts, but also statements that are forward-looking. 

 

Although the forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in herein and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects. Please see “Cautionary Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q for additional information.

 

Overview

 

The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries and professional quality hair and skin care products under various trademarks and brands.

 

The Company has two reportable segments: hair care and skin care, and hearing enhancement and protection.

 

Through our hearing enhancement and protection segment, we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. Through our hair care and skin care segment, we manufacture, market, sell, and distribute professional quality hair and skin care products. 

 

The Company’s overall business strategy is to establish market awareness of our products through our direct-to-consumer campaigns. The Company’s strategy centers on driving growth by expanding market share within existing channels and developing new ones through both online and traditional platforms. The Company’s primary focus is optimizing its e-commerce strategies, building sales teams to meet the needs of distribution channels, and enhancing value through strategic partnerships. The Company is also working to expand its offline retail presence and enter into new international markets. We believe the increase in awareness will allow us to increase distribution and gain customers through our distribution partners’ retail establishments, with the goal of helping us achieve growth in market share and diversify our sales channels; however, we cannot provide any assurances that such increases will occur, or that we will realize the anticipated benefits of our actions.

 

In addition, the Company is exploring options for its hair care and skin care business, which could result in the divestiture of such business. Any such divestiture may not occur in a timely manner, or at all, and the Company may not be able to realize any benefits from any strategic actions it may engage in with respect to its hair care and skin care business.

 

Business Update

 

In light of recent changes to U.S. trade policy, including the imposition of elevated tariffs on certain imported goods, AXIL has accelerated its previously initiated supply chain transition strategy. While we have historically relied on international suppliers for the majority of our manufacturing operations, we began proactively evaluating alternative strategies in anticipation of these risks.

 

To strengthen our long-term operational flexibility and reduce exposure to geopolitical volatility, we have initiated the relocation of senior manufacturing leadership to the United States. This relocation is part of a broader initiative to establish domestic manufacturing capabilities, including the setup of new production facilities. These efforts are expected to improve both cost stability and responsiveness to customer demand over time.

 

Although we anticipate some increase in product costs in the near term as a result of these tariffs, we believe our current inventory levels and ongoing mitigation strategies position us to navigate this period with minimal disruption. We are continuing to evaluate a range of strategic options to manage these cost pressures, including supply chain optimization, pricing strategies, and sourcing adjustments. We believe we will be able to adapt to the evolving trade environment and believe the actions we are taking now will enhance our resilience and competitiveness in the medium and long term. 

  

 -2- 

 

  

Results of Operations

 

Our results of operations are summarized below.

 

    Three months ended     Nine months ended  
    February 28,
2025
    February 29,
2024
    February 28,
2025
    February 29,
2024
 
Sales, net   $ 6,922,367     $ 6,469,343     $ 20,506,213     $ 20,997,289  
 Cost of sales     1,955,939       1,845,017       5,888,090       5,467,458  
 Gross profit     4,966,428       4,624,326       14,618,123       15,529,831  
 Total operating expenses     4,383,319       4,728,205       13,502,845       14,196,041  
 Income (loss) from operations     583,109       (103,879     1,115,278       1,333,790  
 Net income after tax   $ 576,662     $ 781,091     $ 1,100,563     $ 1,953,618  

 

We calculate EBITDA by taking net income calculated in accordance with accounting principles generally accepted in the United States (“GAAP”), and adjusting for income taxes, interest income or expense, and depreciation and amortization. We calculate adjusted EBITDA as EBITDA, further adjusted for stock-based compensation. Adjusted EBITDA is also presented as a percentage of revenue, which is calculated by dividing the non-GAAP Adjusted EBITDA for a period by revenue for the same period. Other companies may calculate EBITDA and adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes. We believe that these non-GAAP measures of financial results provide useful information regarding certain financial and business trends relating to our financial condition and results of operations, and management considers EBITDA and adjusted EBITDA important indicators in evaluating our business on a consistent basis across various periods for trend analyses. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our financial statements and are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. Investors should review the reconciliation of these non-GAAP financial measures to the comparable GAAP financial measure included below. Investors should not rely on any single financial measure to evaluate our business.

 

    For the Three Months Ended     For the Nine Months Ended  
    February 28, 2025     February 29, 2024     February 28, 2025     February 29, 2024  
                         
Net income (GAAP)   $ 576,662     $ 781,091     $ 1,100,563     $ 1,953,618  
Provision (benefit) for income taxes     53,085       (827,436 )     120,335       (397,054 )
Interest income, net     (42,920 )     (51,420 )     (97,595 )     (124,454 )
Depreciation and amortization     45,666       27,614       93,001       83,634  
Total EBITDA (Non-GAAP)     632,493       (70,151 )     1,216,304       1,515,744  
                                 
Adjustments:                                
                                 
Stock-based compensation     258,053       59,099       860,517       161,314  
                                 
Total Adjusted EBTIDA (Non-GAAP)   $ 890,546     $ (11,052 )   $ 2,076,821     $ 1,677,058  
                                 
Sales, net (GAAP)   $ 6,922,367     $ 6,469,343     $ 20,506,213     $ 20,997,289  
                                 
Adjusted EBITDA as a percentage of Sales, net (Non-GAAP)     12.9 %     (0.2 )%     10.1 %     8.0 %

 

 -3- 

 

   

For the Three Months Ended February 28, 2025 Compared to the Three Months Ended February 29, 2024

 

Net sales for the three months ended February 28, 2025 and February 29, 2024 were $6,922,367 and $6,469,343, respectively. Net sales for the three months ended February 28, 2025 increased by $453,024 or 7.0%, as compared to the three months ended February 29, 2024. The increase in sales was primarily attributable to an increase in direct-to-consumer sales that was significantly affected by the shift of post-Thanksgiving holidays falling in the third quarter in fiscal year 2025. Furthermore, we strengthened our distribution channels of AXIL products, expanded our presence in new geographic regions, and increased distributor sales of our hair and skin care products.

 

For the three months ended February 28, 2025, the overall cost of sales increased by $110,922 or 6.0%, as compared to the three months ended February 29, 2024, which was primarily due to the strengthening of our distribution channels in both segments of our business. Cost of sales as a percentage of net revenues for the three months ended February 28, 2025 was 28.3% as compared to 28.5% for the three months ended February 29, 2024.

 

Gross profit for the three months ended February 28, 2025 and February 29, 2024 was $4,966,428 and $4,624,326, respectively. Gross profit as a percentage of sales for the three months ended February 28, 2025 was 71.7%, as compared to 71.5% for the three months ended February 29, 2024.

 

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses decreased by $344,886 or 7.3% from $4,728,205 in the three months ended February 29, 2024 to $4,383,319 in the three months ended February 28, 2025. Operating expense as a percentage of revenue for the three months ended February 28, 2025 was 63.3% compared 73.1% for the three months ended February 29, 2024. Included in operating expenses were non-cash stock-based compensation of $258,053 and $59,099 in the three months ended February 28, 2025 and three months ended February 29, 2024, respectively. The decrease in operating expenses related primarily to lower advertising costs, as we move to a more targeted and efficient approach of advertising for direct-to-consumer sales channels and improve reliance on our distribution channels. During the three months ended February 28, 2025, we incurred approximately $195,000 in consulting fees to support our expansion into new geographic markets, compared to $0 for the same period in 2024. Of this amount, approximately $116,000 was related to stock-based compensation. We have also incurred additional costs related to new product lines. We believe we have not yet realized the anticipated benefits from our recent efforts to expand into new geographic markets and product lines.

 

Income from operations for the three months ended February 28, 2025 was $583,109 compared to a loss from operations of $103,879 for the three months ended February 29, 2024. The increase in income from operations of $686,988 was primarily related to increased sales in both our direct-to-consumer channels as well as our distribution channels, partially offset by an increase in stock-based compensation.

 

For the three months ended February 28, 2025 provision for income taxes was $53,085. For the three months ended February 29, 2024, we had an income tax benefit of $827,436.

 

As a result of the above, we reported a net income of $576,662 and a net income of $781,091 for the three months ended February 28, 2025 and February 29, 2024, respectively.

 

Adjusted EBITDA increased by $901,598 to $890,546 for the three months ended February 28, 2025 from an Adjusted EBITDA loss of $11,052 for the three months ended February 29, 2024. The increase of Adjusted EBITDA related to increased sales in both our direct-to-consumer channels as well as our distribution channels. Adjusted EBITDA as a percentage of sales, net for the three months ended February 28, 2025 and February 29, 2024, was 12.9% and (0.2)%, respectively.

 

For the Nine Months Ended February 28, 2025 Compared to the Nine Months Ended February 29, 2024

 

Net sales for the nine months ended February 28, 2025 and nine months ended February 29, 2024 were $20,506,213 and $20,997,289, respectively. Net sales for the nine months ended February 28, 2025 decreased by $491,076 or 2.3%, as compared to the nine months ended February 29, 2024. This decrease was primarily due to reduced advertising expenditure which adversely affected direct to consumer sales in the first and second quarters of the fiscal year offset by the strong performance of the third quarter.

 

 -4- 

 

   

For the nine months ended February 28, 2025, the overall cost of sales increased by $420,632 or 7.7%, as compared to the nine months ended February 29, 2024. Cost of sales as a percentage of net revenues for the nine months ended February 28, 2025 was 28.7% as compared to 26.0% for the three months ended February 29, 2024. The increase in cost of sales, as a percentage of sales, was primarily attributable to an increase in sales to distributors in both our hair and skin care products and our hearing enhancement and protection segment, bearing lower margins. 

 

Gross profit for the nine months ended February 28, 2025 and February 29, 2024 was $14,618,123 and $15,529,831, respectively. Gross profit as a percentage of sales for the nine months ended February 28, 2025 was 71.3%, as compared to 74.0% for the nine months ended February 29, 2024. The decrease in the gross profit margin for the nine months ended February 28, 2025 was primarily attributable to an increase in cost of sales as a percentage of revenue, and an increase in discounts as a percentage of revenue.

  

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses decreased by $693,196 or 4.9% from $14,196,041 in the nine months ended February 29, 2024 to $13,502,845 in the nine months ended February 28, 2025. Operating expenses as a percentage of net revenues for the nine months ended February 28, 2025 was 65.8% compared to 67.6% for the nine months ended February 29, 2024. Included in operating expenses were non-cash stock-based compensation of $860,517 and $161,314 in the nine months ended February 28, 2025 and February 29, 2024, respectively. The decrease in operating expenses related primarily to a net decrease in advertising expenses, and a forgiveness of account payable amounting to approximately $220,000 partially offset by an increase of stock-based compensation of $699,203 and increased professional and consulting fees. During the nine months ended February 28, 2025, we incurred approximately $395,000 in consulting fees to support our expansion into new geographic markets, compared to $0 for the same period in 2024. Of this amount, approximately $195,000 was related to stock-based compensation. We have also incurred additional costs related to new product lines. We believe we have not yet realized the anticipated benefits from our recent efforts to expand into new geographic markets and product lines.

 

Income from operations for the nine months ended February 28, 2025, was $1,115,278 compared to income of $1,333,790 for the nine months ended February 29, 2024. The decrease in income from operations of $218,512 or 16.4% was primarily related to an increase in our non-cash stock-based compensation.

 

For the nine months ended February 28, 2025, provision for income tax expense was $120,335. For the nine months ended February 29, 2024, income tax benefit was $397,054.

 

As a result of the above, and a gain on settlement of debt of approximately $79,000 in the prior year period that did not recur in the current period, we reported a net income of $1,100,563 and $1,953,618 for the nine months ended February 28, 2025 and February 29, 2024, respectively.

 

Adjusted EBITDA increased by $399,763, or 23.8% from $1,677,058 for the nine months ended February 29, 2024 to $2,076,821 for the nine months ended February 28, 2025. Adjusted EBITDA as a percentage of sales, net for the nine months ended February 28, 2025 and February 29, 2024 was 10.1% and 8.0%, respectively. The increase was primarily due to a strong performance of the third quarter in fiscal year 2025, a forgiveness of account payable amounting to approximately $220,000 and a decrease in advertising expenses.

 

Liquidity and Capital Resources

 

We are currently engaged in product sales and development. Although we earned net income and have cash provided by operations for the nine months ended February 28, 2025, we have incurred operating losses in the past. We currently expect to earn net income and positive cash flows from operations during the current fiscal year ending May 31, 2025. We believe our current cash balances, coupled with anticipated cash flow from operating activities, will be sufficient to meet our working capital requirements for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. We intend to continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use our cash balances in the short-term to invest in revenue growth. As a result of the acquisition of AXIL & Associated Brands’ assets in June 2022, we have generated and expect we will continue to generate sufficient cash for our operational needs, including any required debt payments, for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements. Management is focused on growing the Company’s existing product lines and introducing new products, as well as expanding its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company cannot provide any assurance that it will be able to raise additional capital or obtain necessary financing on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying unaudited consolidated financial statements.

 

 -5- 

 

   

Cash Flows

 

Operating Activities

 

Net cash provided by operating activities for the nine months ended February 28, 2025, was $1,734,230, compared to $339,323 for the nine months ended February 29, 2024. This improvement primarily resulted from our strategic decision to increase inventory levels as of May 31, 2024 to accommodate new product variations and packaging aimed at expanding into new markets. Inventory sold during the nine months ended February 28, 2025 contributed positively to cash flows. We also negotiated a forgiveness of accounts payable during the nine months ended February 28, 2025, resulting in an improvement of operating cash flows of approximately $220,000 offset by timing of net changes in operating assets and liabilities excluding inventory.

 

Investing Activities

 

Net cash flows used in investing activities for the nine months ended February 28, 2025 was $255,778 due to the purchase of intangibles and property and equipment for the Company’s business. For the nine months ended February 29, 2024, net cash flows used in investing activities were $80,192, attributable to the cash used in the purchase of property and equipment primarily relating to our expansion into new product lines.

 

Financing Activities

 

Net cash flows provided by financing activities for the nine months ended February 28, 2025 was $11,142, and were from advances made from a related party of $16,778 partially offset by a repayment of the note payable of $5,636. Net cash flows used in financing activities for the nine months ended February 29, 2024 were $204,246 primarily related to the repayment of note payable of $25,438 and payments to our related party of $176,608.

 

As of February 28, 2025, we had a secured Economic Injury Disaster Loan outstanding, administered pursuant to the CARES Act in the principal amount of $140,958, with a maturity date of May 18, 2050. The Company continues to pay interest and principal on the loan.

 

We are dependent on our product sales to fund our operations and may require additional capital in the future, such as pursuant to the sale of additional common or preferred stock or of debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and more dilutive. Our officers and directors have made no written commitments with respect to providing a source of liquidity in the form of cash advances, loans, and/or financial guarantees. We do not have any plans to seek additional financing at this time and anticipate that our existing cash equivalents and cash provided by operations will be sufficient to meet our working capital requirements. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws.

 

Off-Balance Sheet Arrangements

 

As of February 28, 2025, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Critical Accounting Policies

 

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

 

We believe that the estimates and assumptions that are most important to the portrayal of our financial condition and results of operations, in that they require the most difficult, subjective or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These critical accounting policies relate to revenue recognition, impairment of intangible assets and long-lived assets, inventory, stock compensation, and evaluation of contingencies. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial condition or results of operations.

 

See the footnotes to our unaudited consolidated financial statements for the three and nine months ended February 28, 2025, included with this Quarterly Report on Form 10-Q for additional discussion of our critical accounting policies and use of estimates.

 

 -6- 

 

   

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide the information required by this Item 3.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Executive Officer, and Chief Financial Officer (“CFO”) and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of February 28, 2025. Based on this evaluation of disclosure controls and procedures as of February 28, 2025, our CEO and CFO concluded that our disclosure controls and procedures were effective. 

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act that occurred during the fiscal quarter ended February 28, 2025 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

 -7- 

 

   

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.

 

Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide the information required by this Item 1A.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the third quarter of fiscal year 2025, 3,360,000 shares of the Company’s Series A Preferred Stock were converted into 168,000 shares of common stock. The issuance of these securities was deemed to be exempt from registration pursuant to Section 4(a)(2) of the Securities Act as transactions by the Company not involving a public offering.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION 

 

During the quarter ended February 28, 2025, no director or officer of the Company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

 -8- 

 

   

ITEM 6. EXHIBITS

 

Exhibit       Filed    Furnished
Number   Exhibit Description   herewith   herewith
3.1   Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the SEC on October 6, 2017).        
3.2   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K filed with the SEC on August 25, 2022).        
3.3   Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective as of January 16, 2024 (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 16, 2024).        
3.4   Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective as of February 14, 2024 (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 12, 2024).        
3.5   Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the SEC on October 6, 2017).        
3.6   Amendment to the Bylaws, effective as of February 14, 2024 (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on February 12, 2024).        
10.1*   AXIL Brands, Inc. Amended and Restated 2022 Equity Incentive Plan (effective as of December 18, 2024) (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 18, 2024).        
10.2*   Form of Restricted Stock Award Agreement (2024) (2022 Equity Incentive Plan) (incorporated herein by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on January 8, 2025).        
31.1   Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   X    
31.2   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   X    
32.1   Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.       X
32.2   Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.       X
101   The following unaudited condensed consolidated financial statements from the Quarterly Report on Form 10-Q for the quarter ended February 28, 2025 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Changes in Stockholders’ Equity, (iv) Statements of Cash Flows, and (v) the Notes to Financial Statements.   X    
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).   X    

 

* Management compensatory plan or arrangement. 

 

 -9- 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AXIL BRANDS, INC.
     
Date: April 8, 2025    
     
  By:   /s/ Jeff Toghraie
    Jeff Toghraie
    Chief Executive Officer and Chairman of the Board of Directors
    (Principal Executive Officer)
     
  By: /s/ Jeff Brown
    Jeff Brown
    Chief Financial Officer, Chief Operating Officer and Director
    (Principal Financial Officer and Principal Accounting Officer)

 

 -10- 

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeff Toghraie, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Axil Brands, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

                     
Date: April 8, 2025               By:   /s/ Jeff Toghraie
               

Name:

Title:

 

Jeff Toghraie

Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeff Brown, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Axil Brands, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

                   
Date: April 8, 2025         By:   /s/ Jeff Brown
             

Name:

Title:

 

Jeff Brown

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Axil Brands, Inc. (the “Company”) for the quarter ended February 28, 2025 (the “Report”), I, Jeff Toghraie, Chief Executive Officer, certify as follows:

A)the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and

B)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report.

This statement is authorized to be attached as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference. A signed original of this written statement by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

                   
Date: April 8, 2025         By:   /s/ Jeff Toghraie
             

Name:

Title:

 

Jeff Toghraie

Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Axil Brands, Inc. (the “Company”) for the quarter ended February 28, 2025 (the “Report”), I, Jeff Brown, Chief Financial Officer, certify as follows:

A)the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and

B)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report.

This statement is authorized to be attached as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference. A signed original of this written statement by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

                   
Date: April 8, 2025         By:   /s/ Jeff Brown
             

Name:

Title:

 

Jeff Brown

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

v3.25.1
Cover - shares
9 Months Ended
Feb. 28, 2025
Apr. 07, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Feb. 28, 2025  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --05-31  
Entity File Number 001-41958  
Entity Registrant Name AXIL Brands, Inc.  
Entity Central Index Key 0001718500  
Entity Tax Identification Number 47-4125218  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 9150 Wilshire Boulevard  
Entity Address, Address Line Two Suite 245  
Entity Address, City or Town Beverly Hills  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 90212  
City Area Code 888  
Local Phone Number 638-8883  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol AXIL  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,649,852
v3.25.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Feb. 28, 2025
May 31, 2024
CURRENT ASSETS:    
Cash $ 4,743,470 $ 3,253,876
Accounts receivable, net 801,390 509,835
Inventory, net 2,744,436 3,394,023
Prepaid expenses and other current assets 961,876 809,126
Total Current Assets 9,251,172 7,966,860
OTHER ASSETS:    
Property and equipment, net 375,035 260,948
Intangible assets, net 357,793 309,104
Right of use asset 672,221 36,752
Deferred tax asset 121,791 231,587
Other assets 20,720 16,895
Goodwill 2,152,215 2,152,215
Total Other Assets 3,699,775 3,007,501
TOTAL ASSETS 12,950,947 10,974,361
CURRENT LIABILITIES:    
Accounts payable 896,365 967,596
Customer deposits 38,586 154,762
Contract liabilities- current 786,834 905,311
Notes payable 140,958 146,594
Due to related party 28,576 11,798
Lease liability, current 227,418 36,752
Income tax liability 120,335 242,296
Other current liabilities 210,679 332,936
Total Current Liabilities 2,449,751 2,798,045
LONG TERM LIABILITIES:    
Lease liability, long term 482,842
Contract liabilities- long term 361,488 480,530
Total long term liabilities 844,330 480,530
Total Liabilities 3,294,081 3,278,575
Commitments and contingencies (see Note 10)
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 27,773,500 and 42,251,750 shares issued and outstanding as of February 28, 2025 and May 31, 2024, respectively 2,777 4,225
Common stock, $0.0001 par value: 450,000,000 shares authorized; 6,649,852 and 5,908,939 shares issued and outstanding as of February 28, 2025 and May 31, 2024, respectively 666 591
Additional paid-in capital 8,687,130 7,825,240
Retained Earnings/(Accumulated deficit) 966,293 (134,270)
Total Stockholders’ Equity 9,656,866 7,695,786
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 12,950,947 $ 10,974,361
v3.25.1
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Feb. 28, 2025
May 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 300,000,000 300,000,000
Preferred stock, shares issued 27,773,500 42,251,750
Preferred stock, shares outstanding 27,773,500 42,251,750
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 450,000,000 450,000,000
Common stock, shares issued 6,649,852 5,908,939
Common stock, shares outstanding 6,649,852 5,908,939
v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Income Statement [Abstract]        
Sales, net $ 6,922,367 $ 6,469,343 $ 20,506,213 $ 20,997,289
Cost of sales 1,955,939 1,845,017 5,888,090 5,467,458
Gross profit 4,966,428 4,624,326 14,618,123 15,529,831
OPERATING EXPENSES:        
Sales and marketing 2,994,052 3,398,949 9,041,283 10,278,570
Compensation and related taxes 200,156 228,869 667,478 713,504
Professional and consulting 796,689 687,138 2,480,707 1,990,426
General and administrative 392,422 413,249 1,313,377 1,213,541
Total Operating Expenses 4,383,319 4,728,205 13,502,845 14,196,041
INCOME (LOSS) FROM OPERATIONS 583,109 (103,879) 1,115,278 1,333,790
OTHER INCOME (EXPENSE):        
Gain on settlement 79,182
Other income 3,718 6,114 8,025 19,138
Interest income 44,191 52,915 100,162 129,233
Interest expense and other finance charges (1,271) (1,495) (2,567) (4,779)
Other income (expense), net 46,638 57,534 105,620 222,774
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES 629,747 (46,345) 1,220,898 1,556,564
Provision (benefit) for income taxes 53,085 (827,436) 120,335 (397,054)
NET INCOME $ 576,662 $ 781,091 $ 1,100,563 $ 1,953,618
NET INCOME PER COMMON SHARE:        
Basic $ 0.09 $ 0.13 $ 0.17 $ 0.33
Diluted $ 0.07 $ 0.04 $ 0.13 $ 0.11
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 6,516,852 5,863,939 6,373,502 5,863,939
Diluted 8,202,402 18,576,914 8,196,605 18,569,140
v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at May. 31, 2023 $ 25,000 $ 586 $ 10,113,365 $ (3,466,992) $ 6,671,959
Beginning balance, shares at May. 31, 2023 250,000,000 5,863,939      
Stock options expense 153,320 153,320
Restricted stock awards $ 2 7,992 7,994
Restricted stock awards, shares   15,000      
Net income 1,953,618 1,953,618
Ending balance, value at Feb. 29, 2024 $ 25,000 $ 588 10,274,677 (1,513,374) 8,786,891
Ending balance, shares at Feb. 29, 2024 250,000,000 5,878,939      
Beginning balance, value at Nov. 30, 2023 $ 25,000 $ 586 10,215,580 (2,294,465) 7,946,701
Beginning balance, shares at Nov. 30, 2023 250,000,000 5,863,939      
Stock options expense 51,105 51,105
Restricted stock awards $ 2 7,992 7,994
Restricted stock awards, shares   15,000      
Net income 781,091 781,091
Ending balance, value at Feb. 29, 2024 $ 25,000 $ 588 10,274,677 (1,513,374) 8,786,891
Ending balance, shares at Feb. 29, 2024 250,000,000 5,878,939      
Beginning balance, value at May. 31, 2024 $ 4,225 $ 591 7,825,240 (134,270) 7,695,786
Beginning balance, shares at May. 31, 2024 42,251,750 5,908,939      
Stock options expense 416,935 416,935
Stock based compensation $ 3 443,579 443,582
Stock-based compensation, shares   17,000      
Preferred shares converted to common $ (1,448) $ 72 1,376
Preferred shares converted to common, shares (14,478,250) 723,913      
Net income 1,100,563 1,100,563
Ending balance, value at Feb. 28, 2025 $ 2,777 $ 666 8,687,130 966,293 9,656,866
Ending balance, shares at Feb. 28, 2025 27,773,500 6,649,852      
Beginning balance, value at Nov. 30, 2024 $ 3,113 $ 647 8,428,760 389,631 8,822,151
Beginning balance, shares at Nov. 30, 2024 31,133,500 6,466,852      
Stock options expense 205,880 205,880
Stock based compensation $ 3 52,170 52,173
Stock-based compensation, shares   15,000      
Preferred shares converted to common $ (336) $ 16 320
Preferred shares converted to common, shares (3,360,000) 168,000      
Net income 576,662 576,662
Ending balance, value at Feb. 28, 2025 $ 2,777 $ 666 $ 8,687,130 $ 966,293 $ 9,656,866
Ending balance, shares at Feb. 28, 2025 27,773,500 6,649,852      
v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 1,100,563 $ 1,953,618
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 93,001 83,634
Provision for credit losses 31,834 143,395
Reversal of inventory obsolescence (23,448)
Stock-based compensation 860,517 161,314
Gain on forgiveness of account payable (218,699)
Gain on settlement (79,182)
Deferred income taxes 109,796 (397,054)
Change in operating assets and liabilities:    
Accounts receivable (323,389) (445,883)
Inventory 673,034 (2,131,429)
Prepaid expenses and other current assets (156,574) 145,032
Accounts payable 147,472 1,061,420
Other current liabilities (322,358) (144,052)
Contract liabilities (237,519) (11,490)
NET CASH PROVIDED BY OPERATING ACTIVITIES 1,734,230 339,323
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of intangibles (101,690)
Purchase of property and equipment (154,088) (80,192)
NET CASH USED IN INVESTING ACTIVITIES (255,778) (80,192)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of equipment financing (2,200)
Repayment of note payable (5,636) (25,438)
Advances from (payments to) a related party 16,778 (176,608)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 11,142 (204,246)
NET INCREASE IN CASH 1,489,594 54,885
CASH - Beginning of period 3,253,876 4,832,682
CASH - End of period 4,743,470 4,887,567
Cash paid during the period for:    
Interest 2,567 4,681
Income taxes 132,500
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:    
Initial recognition of right of use assets recognized as lease liability $ 767,269
v3.25.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Pay vs Performance Disclosure [Table]        
Net Income (Loss) $ 576,662 $ 781,091 $ 1,100,563 $ 1,953,618
v3.25.1
Insider Trading Arrangements
9 Months Ended
Feb. 28, 2025
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Organization
9 Months Ended
Feb. 28, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization

Note 1 – Organization

 

As part of AXIL Brands, Inc.’s (together with its subsidiary, the “Company,” “we,” “us” or “our”) ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company’s corporate headquarters are located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Its phone number is (888) 638-8883. In March 2022, the Company incorporated a subsidiary “Reviv3 Acquisition Corporation” (now known as “AXIL Distribution Company”) and in June 2022, completed the acquisition of certain assets of Axil & Associated Brands Corp. (“A&A”). The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality hair and skin care products. These product lines are both sold throughout the United States, Canada, Europe and Asia. On February 14, 2024, the Company successfully completed efforts to uplist from the over-the-counter, (OTC), markets to the NYSE American stock exchange (“NYSE American”).

 

v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies
9 Months Ended
Feb. 28, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of February 28, 2025 and February 29, 2024, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended May 31, 2024. The results of operations for the three and nine months ended February 28, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

Reverse Stock Split

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20 as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

   

Use of estimates

 

The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S.”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash Common Stock issuances. 

 

Reclassifications

 

Certain reclassifications have been made to prior periods to conform with the current year reporting. For the three and nine months ended February 29, 2024, $134,216 and $519,401, respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited Consolidated Statements of Operations. There was no change to total operating expenses for the three and nine months ended February 29, 2024 as a result of this reclassification.

 

Cash and cash equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 12).

 

Accounts receivable and allowance for doubtful accounts

 

On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.

Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold. Prepayments to vendors for inventory was $468,903 and $472,904 as of February 28, 2025 and May 31, 2024, respectively.

 

Inventory

 

The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next 12 months is classified as non-current inventory.

 

Property and Equipment

 

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.

 

Product warranty

 

The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales. 

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.

   

The Company sells a variety of electronic hearing and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.

 

The five steps for the revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories, and service performance obligations include extended warranty coverage.

 

However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.

 

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.

 

As of February 28, 2025, and May 31, 2024, contract liabilities amounted to $1,148,322 and $1,385,841, respectively. As of February 28, 2025, and May 31, 2024, contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $993,427 and $1,251,710, respectively; and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $150,818 and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three years. Approximately $348,088 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized in fiscal year 2026, and $104,356 in fiscal year 2027 and $172,728 in fiscal year 2028. Contract liabilities associated with gift cards purchased by customers amounted to $4,077 and $3,930, respectively as of February 28, 2025 and May 31, 2024.

   

Cost of Sales

 

The primary components of cost of sales include the cost of the product and shipping fees related to product procurement.

 

Shipping and Handling Costs

 

The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses were $253,573 and $313,318 for the three months ended February 28, 2025 and February 29, 2024, respectively. Shipping costs included in marketing and selling expense were $768,625 and $807,333 for the nine months ended February 28, 2025 and February 29, 2024, respectively.

 

Sales, Marketing and Advertising

 

Sales, marketing and advertising costs are expensed as incurred.

 

Customer Deposits

 

Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy. 

 

Fair value measurements and fair value of financial instruments

 

The Company adopted ASC 820, “Fair Value Measurements and Disclosures,” for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: 

 

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
   
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
   
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

   

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.

 

Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.

 

The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.

 

When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).

 

Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the carrying amount exceeds the fair value.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. 

   

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

 

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service (“IRS”) and state taxing authorities, generally for three years after they are filed.

 

Impairment of long-lived assets  

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the three and nine months ended February 28, 2025 and February 29, 2024.

   

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation,” which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

For non-employee stock option based awards, the Company follows Accounting Standards Update (“ASU”) 2018-7, which substantially aligns share based compensation for employees and non-employees.

 

Net income per share of Common Stock

 

Basic net income per share is computed by dividing the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. For the three and nine months ended February 28, 2025 and February 29, 2024, certain stock options, preferred shares and restricted stock awards were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income.

 

The dilutive common stock equivalent shares consist of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market price during the period.

 

The following table sets forth the computations of basic and diluted net income per common share:

 

                    
   For the Three Months Ended   For the Nine Months Ended 
   February 28,   February 29,   February 28,   February 29, 
   2025   2024   2025   2024 
                 
Net income  $576,662   $781,091   $1,100,563   $1,953,618 
                     
Weighted average basic shares   6,516,852    5,863,939    6,373,502    5,863,939 
Dilutive securities:                    
Convertible preferred stock   1,494,008    12,500,000    1,633,277    12,500,000 
Stock options   178,875    212,975    177,221    205,201 
Restricted stock awards   12,667    -    12,605    - 
Weighted average dilutive shares   8,202,402    18,576,914    8,196,605    18,569,140 
                     
Earnings per share:                    
Basic  $0.09   $0.13   $0.17   $0.33 
Diluted  $0.07   $0.04   $0.13   $0.11 

   

Lease Accounting

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company’s consolidated financial statements.

 

The Company renewed its lease for its previous corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expired on December 1, 2024. The Company signed lease agreements in September 2024 for a warehouse along with a new lease for its corporate headquarters commencing October 1, 2024 and November 1, 2024, respectively. Please see Note 10 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.

 

Segment Reporting

 

The Company follows ASC 280, “Segment Reporting.” The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 13 – “Business Segment and Geographic Area Information” for more information about the Company’s reportable segments.

 

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form 10-K for the year ended May 31, 2025.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires entities to provide more detailed disaggregation of expenses in the income statement, focusing on the nature of the expenses rather than their function. The new disclosures will require entities to separately present expenses for significant line items, including but not limited to, depreciation, amortization, and employee compensation. Entities will also be required to provide a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, disclose the total amount of selling expenses and, in annual reporting periods, provide a definition of what constitutes selling expenses. This pronouncement is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements. 

  

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

   

v3.25.1
Accounts Receivable, net
9 Months Ended
Feb. 28, 2025
Credit Loss [Abstract]  
Accounts Receivable, net

Note 3 – Accounts Receivable, net

 

Accounts receivable, net consisted of the following:

 

          
   February 28, 2025   May 31, 2024 
Customers receivable  $776,313   $524,730 
Merchant processor receivable   117,156    78,417 
Less: Allowance for credit losses   (92,079)   (93,312)
Accounts receivables, net  $801,390   $509,835 

 

The Company recorded a provision for credit losses of $3,880 and $79,068 during the three months ended February 28, 2025 and February 29, 2024, respectively. The Company recorded a provision for credit losses of $31,834 and $143,395 during the nine months ended February 28, 2025 and February 29, 2024, respectively. 

 

v3.25.1
Inventory, net
9 Months Ended
Feb. 28, 2025
Inventory Disclosure [Abstract]  
Inventory, net

Note 4 – Inventory, net

 

Inventory consisted of the following:

 

          
   February 28, 2025   May 31, 2024 
Finished Goods  $2,728,309   $3,190,344 
Raw Materials   16,127    203,679 
Inventory  $2,744,436   $3,394,023 

 

As of February 28, 2025 and May 31, 2024, inventory held at third party locations amounted to $322,012 and $58,242, respectively. As of February 28, 2025 and May 31, 2024, inventory in-transit amounted to $127,750 and $15,738, respectively. As of February 28, 2025 and May 31, 2024, the Company had provided $23,448 and $46,895, respectively, as obsolescence reserve on certain slow-moving inventory.

 

v3.25.1
Property and Equipment
9 Months Ended
Feb. 28, 2025
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 5 – Property and Equipment

 

Property and equipment, stated at cost, consisted of the following: 

 

             
   Estimated Life  February 28, 2025   May 31, 2024 
Promotional display racks  2 years  $39,565   $30,709 
Furniture and Fixtures  5 years   67,653    5,759 
Computer Equipment  3 years   18,558    22,130 
Plant Equipment  5-10 years   351,078    264,168 
Office equipment  5-10 years   8,838    8,838 
Automobile  5 years   24,347    24,347 
Less: Accumulated Depreciation      (135,004)   (95,003)
Total Property, plant and equipment, net     $375,035   $260,948 

 

Depreciation expense amounted to $18,703 and $8,237 for the three months ended February 28, 2025 and February 29, 2024, respectively.  Depreciation expense amounted to $40,001 and $25,508 for the nine months ended February 28, 2025 and February 29, 2024, respectively. 

   

v3.25.1
Intangible Assets
9 Months Ended
Feb. 28, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

Note 6 – Intangible Assets

 

The intangible assets consisted of the following:

 

             
   Estimated Life  February 28, 2025   May 31, 2024 
Licensing Rights  3 years  $22,080   $34,024 
Customer Relationships  3 years   70,000    70,000 
Trade Names  10 years   275,000    275,000 
Website  5 years   100,000    100,000 
Product Certification Testing  3 years   101,690    - 
Less: Accumulated Amortization      (210,977)   (169,920)
Intangible assets, net     $357,793   $309,104 

 

Goodwill arising through the business combination in June 2022 was $2,152,215 at February 28, 2025.

 

Amortization expense amounted to $26,963 and $19,375 for the three months ended February 28, 2025 and February 29, 2024, respectively. Amortization expense amounted to $53,000 and $58,126 for the nine months ended February 28, 2025 and February 29, 2024, respectively. 

 

v3.25.1
Other Current Liabilities
9 Months Ended
Feb. 28, 2025
Payables and Accruals [Abstract]  
Other Current Liabilities

Note 7 – Other Current Liabilities

 

Other current liabilities comprised of the following:

 

          
   February 28, 2025   May 31, 2024 
Credit Cards  $245   $5,734 
Royalty Payment Accrual   -    3,376 
Sales Tax Payable   197,536    231,283 
Accrued expenses   12,898    92,543 
Total other current liabilities  $210,679   $332,936 

 

v3.25.1
Notes Payable
9 Months Ended
Feb. 28, 2025
Debt Disclosure [Abstract]  
Notes Payable

Note 8 – Notes Payable

 

During the year ended May 31, 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $150,000, which is administered under the authority and regulations of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the “EIDL”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The Loan, which is evidenced by a note dated May 18, 2020, bears interest at an annual rate of 3.75% and is payable in installments of principal and interest of $731 per month, beginning May 18, 2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively, “qualifying expenses”). The Company used the loan proceeds for qualifying expenses. During the year ended May 31, 2022, the Company received additional $10,000 of borrowings under the program. The Company received a loan forgiveness for $10,000 during the year ended May 31, 2022. The Company recorded interest expense, on the accompanying unaudited consolidated financial statements, of $1,271 and $1,495, during the three months ended February 28, 2025 and February 29, 2024, respectively and $2,567 and $4,779, during the nine months ended February 28, 2025 and February 29, 2024, respectively.

   

As of February 28, 2025 and May 31, 2024, the outstanding balance of the loan amounted to $140,958 and $146,594, respectively.

 

The amounts of loan payments due in the next 12 months from February 28, 2025, are as follows:

 

        
   February 28, 2025   May 31, 2024 
Economic Injury Disaster Loan Program (EIDL)  $140,958   $146,594 

 

v3.25.1
Stockholders’ Equity
9 Months Ended
Feb. 28, 2025
Equity [Abstract]  
Stockholders’ Equity

Note 9 – Stockholders’ Equity

 

Shares Authorized

 

As of February 28, 2025, the authorized capital of the Company consisted of 450,000,000 shares of common stock, par value $0.0001 per share and 300,000,000 shares of preferred stock, par value $0.0001 per share.

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not change the par value of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

 

Preferred Stock

 

The preferred stock may be issued from time to time in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited, or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.

 

During the fiscal year ended May 31, 2023, the Company issued 250,000,000 shares of non-voting Series A Preferred Stock, which, following the Reverse Stock Split of the Company’s common stock, are convertible into shares of the Company’s common stock on a twenty-to-one ratio. These 250,000,000 shares of non-voting Series A Preferred Stock were valued at the fair market value of $3,100,000 at issuance.

   

The holders of shares of Series A Preferred Stock have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock. The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock into one fully paid and nonassessable share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.

 

The conversion provisions of the Company’s Series A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split, and the number of shares of Series A Preferred Stock issued and outstanding was not affected by the Reverse Stock Split.

 

On March 5, 2024, the Company entered into repurchase agreements with certain stockholders of the Company to purchase in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,490. Such repurchase was approved by the Company’s Board of Directors. Following the repurchase, 42,251,750 shares of Series A Preferred Stock remained outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the fiscal year 2024, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.

 

During the nine months ended February 28, 2025, certain stockholders of 14,478,250 preferred shares converted their preferred stock into 723,913 shares of common stock.

 

As of February 28, 2025 and May 31, 2024, 27,773,500 and 42,251,750 shares of Series A Preferred Stock, respectively, were issued and outstanding.

 

Effective March 24, 2025, the Company’s board of directors ratified certain past actions which provided that all shares of preferred stock that were repurchased by the Company along with those that were converted into shares of common stock would be considered retired. The Company retired 222,226,500 Series A preferred shares that were previously repurchased by the Company or converted into shares of common stock prior to such date.

 

Common Stock

 

As of February 28, 2025, 6,649,852 shares of common stock were issued and outstanding. 

 

See Preferred stock and Restricted Stock Awards and Restricted Shares Issued sections within this footnote for detailed discussions of common stock.

 

The Reverse Stock Split as more fully discussed in Note 2, did not change the par value of the common stock, modify any voting rights or other terms of the common stock, or change the number of authorized shares of the Company. Any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share.

  

Stock Options

 

Effective February 14, 2024, the Board amended the Company’s original 2022 Equity Incentive Plan (as amended the “Plan”), which was originally approved on March 21, 2022. The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors, non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i) Incentive Stock Options (to eligible employees only); (ii) Nonqualified Stock Options; (iii) Restricted Stock; (iv) Stock Awards; (v) Performance Shares; or (vi) any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March 21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend or terminate the Plan without stockholder approval, subject to certain exceptions.

 

On October 8, 2024, the Board of Directors approved the amendment and restatement of the Plan in order to increase the number of shares authorized for issuance under the Plan by 800,000 shares, any or all of which may be issued pursuant to grants of “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code). The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.

 

The total number of shares initially authorized for issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option, or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued shares.

 

Two types of options may be granted under the Plan: (1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of the option not less than the fair market value of the common stock on the grant date, or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110% of the fair market value of the common stock on the grant date; and (2) Non-qualified Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value of the common stock on the grant date, but not less than par value of the stock.

 

The Board may grant or sell restricted stock to participants (i.e., shares that are subject to a subject to restrictions or limitations as to the participant’s ability to sell, transfer, pledge or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.

 

Each equity-based award granted under the Plan will be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the Board may determine, consistent with the provisions of the Plan.

   

Subject to the Plan’s terms, the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.

 

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

 

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

 

On January 2, 2025, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on December 31, 2034. The options vest quarterly over a year beginning on March 1, 2025.

 

On November 13, 2024, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.

 

On October 14, 2024, the Company issued to two Company officers stock options to purchase, in the aggregate, up to 600,000 shares of its common stock, at an exercise price of $4.01 per share valued at $2,406,000 and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments starting on the grant date.

 

During the three months ended August 31, 2024, the Company issued stock options, to two consultants, to purchase, in the aggregate, up to 24,000 shares of its common stock, at an exercise price equal to the Company’s closing price on the NYSE American on the date of grant which ranged from $5.94-$10.39. The options are valued at approximately $195,960 and expire in ten years from the date of grant.

   

The following table presents the range of assumptions used to estimate the fair value of the stock options granted during the nine months ended February 28, 2025:

 

   
    February 28, 2025
Risk free interest rate   3.84% - 4.43
Expected life   5 - 7 years
Expected volatility   458% - 467%
Expected dividend   -

 

The following table summarizes the activities for the Company’s stock option activity for the nine months ended February 28, 2025:

 

               
   Number of
Options
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Term
 
Outstanding as of May 31, 2024   268,750   $1.84    7.9 
Granted   634,000    4.17      
Exercised/Forfeited   -    -      
Less: Unvested at February 28, 2025   (571,000)   4.09    6.1 
Vested at February 28, 2025   331,750   $2.42    7.6 

 

During the nine months ended February 28, 2025, the Company expensed $416,935 with respect to options, of which $280,584 was included in General and administrative, and $136,352 in Sales and marketing, respectively, in the accompanying Consolidated Statements of Operations. During the nine months ended February 29, 2024, the Company expensed $153,320 with respect to stock options, which was included in General and administrative in the accompanying Consolidated Statements of Operations.

 

Restricted Stock Awards and Restricted Shares Issued

 

The Company’s non-employee directors participate in the Company’s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan, on January 13, 2025, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $62,250.

 

Effective February 14, 2024, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $195,000.

 

Effective May 28, 2024, a former officer entered into a Separation Agreement and Release (the “Release”), which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting Agreement, dated May 28, 2024, with the former officer (the “Consulting Agreement”), pursuant to which the former officer agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted common stock valued at $298,800, which vested upon grant.

 

Effective November 13, 2024, the Company issued 2,000 shares of restricted common stock to a consultant for services relating to expansion of the Company into new markets. The shares were valued at $8,000 based on the Company’s closing price on the NYSE American on the date of grant. The shares vested upon grant and will be expensed over the six month service period of the consultant beginning from the grant date.

 

The fair value of the stock grants is being recorded over the term of the service related to each grant. During the nine months ended February 28, 2025, the Company expensed $443,582 related to restricted stock awards and restricted stock expense, of which $438,892 was included in General and administrative in the accompanying Consolidated Statements of Operations, and $4,690 in Sales and marketing, in the accompanying Consolidated Statements of Operations. During the nine months ended February 29, 2024, the Company expensed $7,994 related to restricted stock awards and restricted stock expense.

 

v3.25.1
Commitments and Contingencies
9 Months Ended
Feb. 28, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 10 – Commitments and Contingencies

 

Leases

 

The Company treats a contract as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or if the Company directs the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (“ROU”) assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company’s right to use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company’s obligation to make payments over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease. In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, the Company applies a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For variable costs that may change during the lifetime of the lease, the Company expenses as incurred. Since the interest rate implicit in a lease is generally not readily determinable for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease term to obtain an asset of similar value.

 

The Company reviews the impairment of ROU assets consistent with the approach applied for the Company’s other long-lived assets. The Company reviews the recoverability of long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations.

 

Lease expense is recognized on a straight-line basis over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities.

 

During the nine months ended February 28, 2025, the Company entered into two new lease agreements. The Company’s lease agreements do not contain any residual value guarantees or restrictive covenants. The Company’s lease agreements do not have an explicit renewal option, and the termination options are available in the event of material breaches. The expiration dates of the leases are on September 30, 2027 and January 31, 2029.

 

The Company computed an initial lease liability of $767,269 for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement of the leases. During the three months ended February 28, 2025 and February 29, 2024, the Company recorded operating lease costs in the amount of $66,108 and $18,659, respectively. During the nine months ended February 28, 2025 and February 29, 2024, the Company recorded operating lease costs in the amount of $133,847 and $55,976, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses on the accompanying Consolidated Statements of Operations. 

 

The weighted average remaining term and discount rate for the Company’s operating leases as of February 28, 2025 was 3.6 years and 13.0%, respectively.

   

Supplemental balance sheet information related to leases was as follows:

 

          
Assets  February 28, 2025   May 31, 2024 
Right of use assets  $899,239   $131,970 
Accumulated reduction   (227,018)   (95,218)
Operating lease assets, net  $672,221   $36,752 
           
Liabilities          
Lease liability  $899,239   $131,970 
Accumulated reduction   (188,979)   (95,218)
Total lease liability, net   710,260    36,752 
Current portion   (227,418)   (36,752)
Non-current portion  $482,842   $- 

 

Maturities of operating lease liabilities were as follows as of February 28, 2025:

 

     
Operating Lease (fiscal year-end)    
2025 (three months remaining)  $65,675 
2026   258,005 
2027   269,437 
2028   218,420 
2029   128,040 
Total  $939,577 
Less: Imputed interest   (229,317)
Present value of lease liabilities  $710,260 

 

Accounts Payable

 

During the nine months ended February 28, 2025, the Company renewed its relationship with an entity, and as a result of the agreement, $218,699 previously due in relation to royalties, was forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations.

 

Contingencies

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

v3.25.1
Related Party Transactions
9 Months Ended
Feb. 28, 2025
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

The Company’s Chairman and Chief Executive Officer (“CEO”), Jeff Toghraie, is the managing director of Intrepid Global Advisors (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the year. Intrepid was paid approximately $178,000 in consulting fees for the nine months ended February 28, 2025. As of February 28, 2025 and May 31, 2024, the Company had amounts payable to Intrepid of $28,576 and $11,798, respectively. These advances were short-term in nature and non-interest bearing. The Company’s Board Member, Chief Financial Officer ("CFO"), and Chief Operating Officer ("COO") has a controlling interest in BZ Capital Strategies. BZ Capital Strategies was paid $100,000 in consulting fees for the nine months ended February 28, 2025.

 

v3.25.1
Concentrations
9 Months Ended
Feb. 28, 2025
Risks and Uncertainties [Abstract]  
Concentrations

Note 12 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents instruments. The Company maintains its cash in bank deposits accounts. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At February 28, 2025 and May 31, 2024, the Company held cash of approximately $3,993,470 and $3,003,876, respectively, in excess of federally insured limits. The Company has not experienced any losses in such accounts through February 28, 2025.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier

 

The Company predominantly sells the products direct-to-consumer. There was no single customer that accounted for greater than 10% of consolidated net sales for the three and nine months ended February 28, 2025 and February 29, 2024.

 

During the three months ended February 28, 2025, approximately 92.8% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). During the three months ended February 29, 2024, approximately 96.1% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). All Company assets are located in the U.S.

 

During the nine months ended February 28, 2025, approximately 91.1% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). During the nine months ended February 29, 2024, approximately 93.9% of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address).

 

As of February 28, 2025, accounts receivable from customers that accounted for more than 10% of sales transactions were from two customers amounting to 38.9%. As of May 31, 2024, no single customer accounted for more than 10% of accounts receivable.

 

Manufacturing is outsourced primarily overseas via a number of third-party vendors. The two largest vendors accounted for 68.3% and 26.2%, respectively, of all purchases for the three months ended February 28, 2025. For the nine months ended February 28, 2025, the two largest manufacturing vendors accounted for  65.1% and 26.5%, respectively. For the three months ended February 29, 2024, the two largest manufacturing vendors accounted for 76.0% and 12.2%, respectively. For the nine months ended February 29, 2024, one vendor accounted for 84.8% for all inventory purchases.

   

v3.25.1
Business Segment and Geographic Area Information
9 Months Ended
Feb. 28, 2025
Segment Reporting [Abstract]  
Business Segment and Geographic Area Information

Note 13 – Business Segment and Geographic Area Information

 

Business Segments

 

The Company, directly or through its subsidiaries, markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing enhancement and hearing protection business. The Company’s determination of its reportable segments is based on how its chief operating decision makers manage the business. 

  

The Company’s segment information is as follows:

 

                    
  Three months ended   Nine months ended 
   February 28, 2025   February 29, 2024   February 28, 2025   February 29, 2024 
Sales, net                    
Hair care and skin care  $472,302   $476,864   $1,308,356   $1,022,458 
Hearing enhancement and protection   6,450,065    5,992,479    19,197,857    19,974,831 
Total net sales  $6,922,367   $6,469,343   $20,506,213   $20,997,289 
                     
Operating earnings (loss)                    
Segment gross profit:                    
Hair care and skin care  $255,968   $247,859   $685,964   $641,966 
Hearing enhancement and protection   4,710,460    4,376,467    13,932,159    14,887,865 
Total segment gross profit   4,966,428    4,624,326    14,618,123    15,529,831 
Selling and Marketing   2,994,052    3,398,949    9,041,283    10,278,570 
General and Administrative   1,389,267    1,329,256    4,461,562    3,917,471 
Consolidated operating income (loss)  $583,109   $(103,879  $1,115,278   $1,333,790 
                     
Total Assets:                    
Hair care and skin care  $4,647,830   $4,232,913   $4,647,830   $4,232,913 
Hearing enhancement and protection   8,303,317    8,480,805    8,303,317    8,480,805 
Consolidated total assets  $12,950,947   $12,713,718   $12,950,947   $12,713,718 
                     
Payments for property and equipment and intangible assets                    
Hair care and skin care  $1,870   $-   $1,870   $- 
Hearing enhancement and protection   146,285    9,347    253,908    80,192 
Consolidated total payments for property and equipment and intangible assets  $148,155   $9,347   $255,778   $80,192 
                     
Depreciation and amortization                    
Hair care and skin care  $932   $1,417   $2,610   $4,251 
Hearing enhancement and protection   44,734    26,197    90,391    79,383 
Consolidated total depreciation and amortization  $45,666   $27,614   $93,001   $83,634 

 

Geographic Area Information

 

For geographic area information of sales for the three and nine months ended February 28, 2025 see Note 12 – Concentrations.

 

v3.25.1
Income Taxes
9 Months Ended
Feb. 28, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

Note 14 – Income Taxes

 

We calculated our interim tax provision in accordance with ASC 270, “Interim Reporting,” and ASC 740, “Accounting for Income Taxes.” As the end of each interim quarterly period, we estimate our annual effective tax rate and apply that rate to our ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects of other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.

 

We recorded an income tax expense of $53,085 for the three months ended February 28, 2025 and an income tax benefit of $827,436 for the three months ended February 29, 2024. We recorded an income tax expense of $120,335 for the nine months ended February 28, 2025 and an income tax benefit of $397,054 for the nine months ended February 29, 2024.

 

The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company’s 2021, 2022, 2023 and 2024 Corporate Income Tax Returns are subject to IRS examination.  

v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Feb. 28, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of February 28, 2025 and February 29, 2024, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. Certain information and note disclosures normally included in our annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been omitted. The unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended May 31, 2024. The results of operations for the three and nine months ended February 28, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending May 31, 2025. The unaudited consolidated financial statements include the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

Reverse Stock Split

Reverse Stock Split

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20 as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying unaudited consolidated financial statements and notes to the consolidated financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

   

Use of estimates

Use of estimates

 

The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S.”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets and the fair value of non-cash Common Stock issuances. 

 

Reclassifications

Reclassifications

 

Certain reclassifications have been made to prior periods to conform with the current year reporting. For the three and nine months ended February 29, 2024, $134,216 and $519,401, respectively, were reclassified from General and administrative to Professional and consulting on the accompanying unaudited Consolidated Statements of Operations. There was no change to total operating expenses for the three and nine months ended February 29, 2024 as a result of this reclassification.

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 12).

 

Accounts receivable and allowance for doubtful accounts

Accounts receivable and allowance for doubtful accounts

 

On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.

Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Prepaid expenses and other current assets

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold. Prepayments to vendors for inventory was $468,903 and $472,904 as of February 28, 2025 and May 31, 2024, respectively.

 

Inventory

Inventory

 

The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next 12 months is classified as non-current inventory.

 

Property and Equipment

Property and Equipment

 

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statements of operations.

 

Product warranty

Product warranty

 

The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales. 

 

Revenue recognition

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.

   

The Company sells a variety of electronic hearing and enhancement products and hair and skin care products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.

 

The five steps for the revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories, and service performance obligations include extended warranty coverage.

 

However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to hearing enhancement and protection products and hair and skincare products, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.

 

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.

 

As of February 28, 2025, and May 31, 2024, contract liabilities amounted to $1,148,322 and $1,385,841, respectively. As of February 28, 2025, and May 31, 2024, contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $993,427 and $1,251,710, respectively; and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $150,818 and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three years. Approximately $348,088 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized in fiscal year 2026, and $104,356 in fiscal year 2027 and $172,728 in fiscal year 2028. Contract liabilities associated with gift cards purchased by customers amounted to $4,077 and $3,930, respectively as of February 28, 2025 and May 31, 2024.

   

Cost of Sales

Cost of Sales

 

The primary components of cost of sales include the cost of the product and shipping fees related to product procurement.

 

Shipping and Handling Costs

Shipping and Handling Costs

 

The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expenses were $253,573 and $313,318 for the three months ended February 28, 2025 and February 29, 2024, respectively. Shipping costs included in marketing and selling expense were $768,625 and $807,333 for the nine months ended February 28, 2025 and February 29, 2024, respectively.

 

Sales, Marketing and Advertising

Sales, Marketing and Advertising

 

Sales, marketing and advertising costs are expensed as incurred.

 

Customer Deposits

Customer Deposits

 

Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy. 

 

Fair value measurements and fair value of financial instruments

Fair value measurements and fair value of financial instruments

 

The Company adopted ASC 820, “Fair Value Measurements and Disclosures,” for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: 

 

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
   
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
   
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

   

Business Combinations

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.

 

Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.

 

Goodwill

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.

 

The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.

 

When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).

 

Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the carrying amount exceeds the fair value.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. 

   

Income Taxes

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

 

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service (“IRS”) and state taxing authorities, generally for three years after they are filed.

 

Impairment of long-lived assets

Impairment of long-lived assets  

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the three and nine months ended February 28, 2025 and February 29, 2024.

   

Stock-based compensation

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation,” which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

For non-employee stock option based awards, the Company follows Accounting Standards Update (“ASU”) 2018-7, which substantially aligns share based compensation for employees and non-employees.

 

Net income per share of Common Stock

Net income per share of Common Stock

 

Basic net income per share is computed by dividing the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. For the three and nine months ended February 28, 2025 and February 29, 2024, certain stock options, preferred shares and restricted stock awards were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income.

 

The dilutive common stock equivalent shares consist of preferred stock, stock options, and restricted stock awards were computed under the treasury stock method, using the average market price during the period.

 

The following table sets forth the computations of basic and diluted net income per common share:

 

                    
   For the Three Months Ended   For the Nine Months Ended 
   February 28,   February 29,   February 28,   February 29, 
   2025   2024   2025   2024 
                 
Net income  $576,662   $781,091   $1,100,563   $1,953,618 
                     
Weighted average basic shares   6,516,852    5,863,939    6,373,502    5,863,939 
Dilutive securities:                    
Convertible preferred stock   1,494,008    12,500,000    1,633,277    12,500,000 
Stock options   178,875    212,975    177,221    205,201 
Restricted stock awards   12,667    -    12,605    - 
Weighted average dilutive shares   8,202,402    18,576,914    8,196,605    18,569,140 
                     
Earnings per share:                    
Basic  $0.09   $0.13   $0.17   $0.33 
Diluted  $0.07   $0.04   $0.13   $0.11 

   

Lease Accounting

Lease Accounting

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC 840). Under the new guidance, codified as ASC 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense is generally flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC 842 effective June 1, 2019. The adoption of ASC 842 did not have a material impact on the Company’s consolidated financial statements.

 

The Company renewed its lease for its previous corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease, which expired on December 1, 2024. The Company signed lease agreements in September 2024 for a warehouse along with a new lease for its corporate headquarters commencing October 1, 2024 and November 1, 2024, respectively. Please see Note 10 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.

 

Segment Reporting

Segment Reporting

 

The Company follows ASC 280, “Segment Reporting.” The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 13 – “Business Segment and Geographic Area Information” for more information about the Company’s reportable segments.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt the ASU and will make the applicable disclosures, as required, on its Annual Report Form 10-K for the year ended May 31, 2025.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires entities to provide more detailed disaggregation of expenses in the income statement, focusing on the nature of the expenses rather than their function. The new disclosures will require entities to separately present expenses for significant line items, including but not limited to, depreciation, amortization, and employee compensation. Entities will also be required to provide a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, disclose the total amount of selling expenses and, in annual reporting periods, provide a definition of what constitutes selling expenses. This pronouncement is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements. 

  

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

   

v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Feb. 28, 2025
Accounting Policies [Abstract]  
Schedule of net loss per share
                    
   For the Three Months Ended   For the Nine Months Ended 
   February 28,   February 29,   February 28,   February 29, 
   2025   2024   2025   2024 
                 
Net income  $576,662   $781,091   $1,100,563   $1,953,618 
                     
Weighted average basic shares   6,516,852    5,863,939    6,373,502    5,863,939 
Dilutive securities:                    
Convertible preferred stock   1,494,008    12,500,000    1,633,277    12,500,000 
Stock options   178,875    212,975    177,221    205,201 
Restricted stock awards   12,667    -    12,605    - 
Weighted average dilutive shares   8,202,402    18,576,914    8,196,605    18,569,140 
                     
Earnings per share:                    
Basic  $0.09   $0.13   $0.17   $0.33 
Diluted  $0.07   $0.04   $0.13   $0.11 
v3.25.1
Accounts Receivable, net (Tables)
9 Months Ended
Feb. 28, 2025
Credit Loss [Abstract]  
Schedule of accounts receivable
          
   February 28, 2025   May 31, 2024 
Customers receivable  $776,313   $524,730 
Merchant processor receivable   117,156    78,417 
Less: Allowance for credit losses   (92,079)   (93,312)
Accounts receivables, net  $801,390   $509,835 
v3.25.1
Inventory, net (Tables)
9 Months Ended
Feb. 28, 2025
Inventory Disclosure [Abstract]  
Schedule of inventory
          
   February 28, 2025   May 31, 2024 
Finished Goods  $2,728,309   $3,190,344 
Raw Materials   16,127    203,679 
Inventory  $2,744,436   $3,394,023 
v3.25.1
Property and Equipment (Tables)
9 Months Ended
Feb. 28, 2025
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
             
   Estimated Life  February 28, 2025   May 31, 2024 
Promotional display racks  2 years  $39,565   $30,709 
Furniture and Fixtures  5 years   67,653    5,759 
Computer Equipment  3 years   18,558    22,130 
Plant Equipment  5-10 years   351,078    264,168 
Office equipment  5-10 years   8,838    8,838 
Automobile  5 years   24,347    24,347 
Less: Accumulated Depreciation      (135,004)   (95,003)
Total Property, plant and equipment, net     $375,035   $260,948 
v3.25.1
Intangible Assets (Tables)
9 Months Ended
Feb. 28, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets
             
   Estimated Life  February 28, 2025   May 31, 2024 
Licensing Rights  3 years  $22,080   $34,024 
Customer Relationships  3 years   70,000    70,000 
Trade Names  10 years   275,000    275,000 
Website  5 years   100,000    100,000 
Product Certification Testing  3 years   101,690    - 
Less: Accumulated Amortization      (210,977)   (169,920)
Intangible assets, net     $357,793   $309,104 
v3.25.1
Other Current Liabilities (Tables)
9 Months Ended
Feb. 28, 2025
Payables and Accruals [Abstract]  
Schedule of other current liabilities
          
   February 28, 2025   May 31, 2024 
Credit Cards  $245   $5,734 
Royalty Payment Accrual   -    3,376 
Sales Tax Payable   197,536    231,283 
Accrued expenses   12,898    92,543 
Total other current liabilities  $210,679   $332,936 
v3.25.1
Notes Payable (Tables)
9 Months Ended
Feb. 28, 2025
Debt Disclosure [Abstract]  
Schedule of notes payments due in the next twelve months
        
   February 28, 2025   May 31, 2024 
Economic Injury Disaster Loan Program (EIDL)  $140,958   $146,594 
v3.25.1
Stockholders’ Equity (Tables)
9 Months Ended
Feb. 28, 2025
Equity [Abstract]  
Schedule of stock option assumptions
   
    February 28, 2025
Risk free interest rate   3.84% - 4.43
Expected life   5 - 7 years
Expected volatility   458% - 467%
Expected dividend   -
Schedule of stock options activity
               
   Number of
Options
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Term
 
Outstanding as of May 31, 2024   268,750   $1.84    7.9 
Granted   634,000    4.17      
Exercised/Forfeited   -    -      
Less: Unvested at February 28, 2025   (571,000)   4.09    6.1 
Vested at February 28, 2025   331,750   $2.42    7.6 
v3.25.1
Commitments and Contingencies (Tables)
9 Months Ended
Feb. 28, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of supplemental balance sheet information
          
Assets  February 28, 2025   May 31, 2024 
Right of use assets  $899,239   $131,970 
Accumulated reduction   (227,018)   (95,218)
Operating lease assets, net  $672,221   $36,752 
           
Liabilities          
Lease liability  $899,239   $131,970 
Accumulated reduction   (188,979)   (95,218)
Total lease liability, net   710,260    36,752 
Current portion   (227,418)   (36,752)
Non-current portion  $482,842   $- 
Schedule of maturities of operating lease liabilities
     
Operating Lease (fiscal year-end)    
2025 (three months remaining)  $65,675 
2026   258,005 
2027   269,437 
2028   218,420 
2029   128,040 
Total  $939,577 
Less: Imputed interest   (229,317)
Present value of lease liabilities  $710,260 
v3.25.1
Business Segment and Geographic Area Information (Tables)
9 Months Ended
Feb. 28, 2025
Segment Reporting [Abstract]  
Schedule of segment information
                    
  Three months ended   Nine months ended 
   February 28, 2025   February 29, 2024   February 28, 2025   February 29, 2024 
Sales, net                    
Hair care and skin care  $472,302   $476,864   $1,308,356   $1,022,458 
Hearing enhancement and protection   6,450,065    5,992,479    19,197,857    19,974,831 
Total net sales  $6,922,367   $6,469,343   $20,506,213   $20,997,289 
                     
Operating earnings (loss)                    
Segment gross profit:                    
Hair care and skin care  $255,968   $247,859   $685,964   $641,966 
Hearing enhancement and protection   4,710,460    4,376,467    13,932,159    14,887,865 
Total segment gross profit   4,966,428    4,624,326    14,618,123    15,529,831 
Selling and Marketing   2,994,052    3,398,949    9,041,283    10,278,570 
General and Administrative   1,389,267    1,329,256    4,461,562    3,917,471 
Consolidated operating income (loss)  $583,109   $(103,879  $1,115,278   $1,333,790 
                     
Total Assets:                    
Hair care and skin care  $4,647,830   $4,232,913   $4,647,830   $4,232,913 
Hearing enhancement and protection   8,303,317    8,480,805    8,303,317    8,480,805 
Consolidated total assets  $12,950,947   $12,713,718   $12,950,947   $12,713,718 
                     
Payments for property and equipment and intangible assets                    
Hair care and skin care  $1,870   $-   $1,870   $- 
Hearing enhancement and protection   146,285    9,347    253,908    80,192 
Consolidated total payments for property and equipment and intangible assets  $148,155   $9,347   $255,778   $80,192 
                     
Depreciation and amortization                    
Hair care and skin care  $932   $1,417   $2,610   $4,251 
Hearing enhancement and protection   44,734    26,197    90,391    79,383 
Consolidated total depreciation and amortization  $45,666   $27,614   $93,001   $83,634 
v3.25.1
Basis of Presentation and Summary of Significant Accounting (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Accounting Policies [Abstract]        
Net income $ 576,662 $ 781,091 $ 1,100,563 $ 1,953,618
Weighted average basic shares 6,516,852 5,863,939 6,373,502 5,863,939
Dilutive securities:        
Convertible preferred stock 1,494,008 12,500,000 1,633,277 12,500,000
Stock options 178,875 212,975 177,221 205,201
Restricted stock awards 12,667 12,605
Weighted average dilutive shares 8,202,402 18,576,914 8,196,605 18,569,140
Earnings per share:        
Basic $ 0.09 $ 0.13 $ 0.17 $ 0.33
Diluted $ 0.07 $ 0.04 $ 0.13 $ 0.11
v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
May 31, 2024
Stockholders' Equity, Reverse Stock Split     1-for-20    
Professional and consulting $ 796,689 $ 687,138 $ 2,480,707 $ 1,990,426  
Prepaid expenses 468,903   468,903   $ 472,904
Contract liabilities 1,148,322   $ 1,148,322   $ 1,385,841
Contract Liabilities Description     contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one, two and three years was $993,427 and $1,251,710, respectively; and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $150,818 and $130,201, respectively. Our contract liabilities amounts are expected to be recognized over a period of between one year to three years. Approximately $348,088 is expected to be recognized in the remainder of the fiscal year, $523,150 is expected to be recognized in fiscal year 2026, and $104,356 in fiscal year 2027 and $172,728 in fiscal year 2028. Contract liabilities associated with gift cards purchased by customers amounted to $4,077 and $3,930, respectively as of February 28, 2025 and May 31, 2024.    
Selling and marketing expense 2,994,052 3,398,949 $ 9,041,283 10,278,570  
Impairment loss 0 0 0 0  
Customer [Member]          
Selling and marketing expense $ 253,573 313,318 $ 768,625 807,333  
General and Administrative Expense [Member]          
Professional and consulting   $ 134,216   $ 519,401  
v3.25.1
Accounts Receivable, net (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Credit Loss [Abstract]    
Customers receivable $ 776,313 $ 524,730
Merchant processor receivable 117,156 78,417
Less: Allowance for credit losses (92,079) (93,312)
Accounts receivables, net $ 801,390 $ 509,835
v3.25.1
Accounts Receivable, net (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Credit Loss [Abstract]        
Provision for credit losses $ 3,880 $ 79,068 $ 31,834 $ 143,395
v3.25.1
Inventory, net (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Inventory Disclosure [Abstract]    
Finished Goods $ 2,728,309 $ 3,190,344
Raw Materials 16,127 203,679
Inventory $ 2,744,436 $ 3,394,023
v3.25.1
Inventory, net (Details Narrative) - USD ($)
Feb. 28, 2025
May 31, 2024
Inventory Disclosure [Abstract]    
Inventory held at third party location $ 322,012 $ 58,242
Inventory in-transit 127,750 15,738
Inventory valuation reserves $ 23,448 $ 46,895
v3.25.1
Property and Equipment (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Property, Plant and Equipment [Line Items]    
Less:Accumulated Depreciation $ (135,004) $ (95,003)
Property and equipment, net $ 375,035 260,948
Promotional Risplay Racks [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 2 years  
Plant Equipment $ 39,565 30,709
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Plant Equipment $ 67,653 5,759
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Plant Equipment $ 18,558 22,130
Property, Plant and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Plant Equipment $ 351,078 264,168
Property, Plant and Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Property, Plant and Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 10 years  
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Plant Equipment $ 8,838 8,838
Office Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Office Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 10 years  
Automobiles [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Plant Equipment $ 24,347 $ 24,347
v3.25.1
Property and Equipment (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Property, Plant and Equipment [Abstract]        
Depreciation $ 18,703 $ 8,237 $ 40,001 $ 25,508
v3.25.1
Intangible Assets (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Less: Accumulated Amortization $ (210,977) $ (169,920)
Finite-lived Intangible Assets, Net $ 357,793 309,104
Licensing Rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 3 years  
Finite-lived Intangible Assets, Gross $ 22,080 34,024
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 3 years  
Finite-lived Intangible Assets, Gross $ 70,000 70,000
Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 10 years  
Finite-lived Intangible Assets, Gross $ 275,000 275,000
Website [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 5 years  
Finite-lived Intangible Assets, Gross $ 100,000 100,000
Product Certification Testing [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 3 years  
Finite-lived Intangible Assets, Gross $ 101,690
v3.25.1
Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]        
Goodwill $ 2,152,215   $ 2,152,215  
Amortization expense $ 26,963 $ 19,375 $ 53,000 $ 58,126
v3.25.1
Other Current Liabilities (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Payables and Accruals [Abstract]    
Credit Cards $ 245 $ 5,734
Royalty Payment Accrual 3,376
Sales Tax Payable 197,536 231,283
Accrued expenses 12,898 92,543
Total other current liabilities $ 210,679 $ 332,936
v3.25.1
Notes Payable (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Debt Disclosure [Abstract]    
Economic Injury Disaster Loan Program (EIDL) $ 140,958 $ 146,594
v3.25.1
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 18, 2020
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
May 31, 2022
May 31, 2024
May 31, 2020
Debt Instrument [Line Items]                
Accrued interest   $ 1,271 $ 1,495 $ 2,567 $ 4,779      
Economic Injury Disaster Loan Program [Member]                
Debt Instrument [Line Items]                
Face Amount               $ 150,000
Interest rate 3.75%              
Loan forgiveness           $ 10,000    
Additional borrowings           $ 10,000    
Accrued interest   1,271 $ 1,495 2,567 $ 4,779      
Accrued interest   2,567   2,567        
EIDL [Member]                
Debt Instrument [Line Items]                
Face Amount   $ 140,958   $ 140,958     $ 146,594  
v3.25.1
Stockholders' Equity (Details)
9 Months Ended
Feb. 28, 2025
Expected dividend (0.00%)
Minimum [Member]  
Risk free interest rate 3.84%
Expected life 5 years
Expected volatility 458.00%
Maximum [Member]  
Risk free interest rate 4.43%
Expected life 7 years
Expected volatility 467.00%
v3.25.1
Stockholders' Equity (Details 1) - $ / shares
9 Months Ended 12 Months Ended
Feb. 28, 2025
May 31, 2024
Equity [Abstract]    
Number of Options Outstanding, Beginning 268,750  
Weighted Average Exercise Price, Beginning $ 1.84  
Weighted Average Remaining Term 6 years 1 month 6 days 7 years 10 months 24 days
Number of Options Outstanding, Granted 634,000  
Weighted Average Exercise Price, Granted $ 4.17  
Number of Options Outstanding, Exercised/Forfeited  
Weighted Average Exercise Price, Exercised/Forfeited  
Number of Options Outstanding, Ending (571,000) (268,750)
Weighted Average Exercise Price, Ending $ 4.09 $ 1.84
Number of Options Outstanding, Vested 331,750  
Weighted Average Exercise Price, Vested $ 2.42  
Weighted Average Remaining Term, Vested 7 years 7 months 6 days  
v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Jan. 13, 2025
Nov. 13, 2024
Mar. 05, 2024
Feb. 14, 2024
Mar. 24, 2025
Feb. 28, 2025
Feb. 29, 2024
May 31, 2023
Jan. 02, 2025
Oct. 14, 2024
Aug. 31, 2024
May 31, 2024
Class of Stock [Line Items]                        
Common stock, shares authorized           450,000,000           450,000,000
Common stock, par or stated value per share           $ 0.0001           $ 0.0001
Preferred stock, shares authorized           300,000,000           300,000,000
Preferred stock, par or stated value per share           $ 0.0001           $ 0.0001
Reverse stock split           1-for-20            
Shares issued during the period               250,000,000        
Shares issued value during the period               $ 3,100,000        
Preferred stock, shares issued           27,773,500           42,251,750
Preferred stock, shares outstanding           27,773,500           42,251,750
Common stock, shares issued           6,649,852           5,908,939
Common stock, shares outstanding           6,649,852           5,908,939
Exercise price           $ 4.09           $ 1.84
Stock-based compensation expense           $ 860,517 $ 161,314          
Restricted Stock Awards [Member]                        
Class of Stock [Line Items]                        
Stock-based compensation expense           $ 443,582 $ 7,994          
Three Non Employee Directors Board Member [Member]                        
Class of Stock [Line Items]                        
Number of restricted stock awards issued 15,000     15,000                
Fair value of restricted stock $ 62,250     $ 195,000                
One Employee [Member]                        
Class of Stock [Line Items]                        
Number of option issued                 5,000      
Exercise price                 $ 4.00      
Value of option issued                 $ 20,000      
One Employee One [Member]                        
Class of Stock [Line Items]                        
Number of option issued   5,000                    
Exercise price   $ 4.00                    
Value of option issued   $ 20,000                    
Officers [Member]                        
Class of Stock [Line Items]                        
Number of option issued                   600,000    
Exercise price                   $ 4.01    
Value of option issued                   $ 2,406,000    
Two Consultants [Member]                        
Class of Stock [Line Items]                        
Number of option issued                     24,000  
Value of option issued                     $ 195,960  
Two Consultants [Member] | Minimum [Member]                        
Class of Stock [Line Items]                        
Exercise price                     $ 5.94  
Two Consultants [Member] | Maximum [Member]                        
Class of Stock [Line Items]                        
Exercise price                     $ 10.39  
One Consultant [Member]                        
Class of Stock [Line Items]                        
Stock issued for services   2,000                    
Stock issued for valued   $ 8,000                    
Preferred Stock [Member]                        
Class of Stock [Line Items]                        
Number of share purchased     207,748,250                  
Cash consideration     $ 1,246,490                  
Remaining outstanding           42,251,750            
Common Stock [Member]                        
Class of Stock [Line Items]                        
Number of shares converted           723,913            
Series A Preferred Stock [Member]                        
Class of Stock [Line Items]                        
Stock repurchased and retired shares         222,226,500              
v3.25.1
Commitments and Contingencies (Details) - USD ($)
Feb. 28, 2025
May 31, 2024
Assets    
Right of use assets $ 899,239 $ 131,970
Accumulated reduction (227,018) (95,218)
Operating lease assets, net 672,221 36,752
Liabilities    
Lease liability 899,239 131,970
Accumulated reduction (188,979) (95,218)
Total lease liability, net 710,260 36,752
Current portion (227,418) (36,752)
Non-current portion $ 482,842
v3.25.1
Commitments and Contingencies (Details 1) - USD ($)
Feb. 28, 2025
May 31, 2024
Commitments and Contingencies Disclosure [Abstract]    
2025 (three months remaining) $ 65,675  
2026 258,005  
2027 269,437  
2028 218,420  
2029 128,040  
Total 939,577  
Less: Imputed interest (229,317)  
Present value of lease liabilities $ 710,260 $ 36,752
v3.25.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]        
Initial lease liability $ 767,269   $ 767,269  
Operating lease cost $ 66,108 $ 18,659 $ 133,847 $ 55,976
Lease term 3 years 7 months 6 days   3 years 7 months 6 days  
Discount rate 13.00%   13.00%  
Due in royalties $ 218,699   $ 218,699  
v3.25.1
Related Party Transactions (Details Narrative) - USD ($)
9 Months Ended
Feb. 28, 2025
May 31, 2024
BZ Capital Strategies [Member]    
Related Party Transaction [Line Items]    
Consulting fee $ 100,000  
Intrepid [Member]    
Related Party Transaction [Line Items]    
Consulting fee 178,000  
Payable to related party $ 28,576 $ 11,798
v3.25.1
Concentrations (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
May 31, 2024
Concentration Risk [Line Items]          
Cash, FDIC insured amount $ 250,000   $ 250,000    
Cash, uninsured amount $ 3,993,470   $ 3,993,470   $ 3,003,876
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage 92.80% 96.10% 91.10% 93.90%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage     38.90%    
Purchases [Member] | Product Concentration Risk [Member] | Vendors [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage 68.30% 76.00% 65.10%    
Purchases [Member] | Product Concentration Risk [Member] | Vendors One [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage 26.20% 12.20% 26.50% 84.80%  
v3.25.1
Business Segment and Geographic Area Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Segment Reporting Information [Line Items]        
Total net sales $ 6,922,367 $ 6,469,343 $ 20,506,213 $ 20,997,289
Total segment gross profit 4,966,428 4,624,326 14,618,123 15,529,831
Selling and Marketing 2,994,052 3,398,949 9,041,283 10,278,570
General and Administrative 1,389,267 1,329,256 4,461,562 3,917,471
Consolidated operating income (loss) 583,109 (103,879) 1,115,278 1,333,790
Consolidated total assets 12,950,947 12,713,718 12,950,947 12,713,718
Consolidated total payments for property and equipment and intangible assets 148,155 9,347 255,778 80,192
Consolidated total depreciation and amortization 45,666 27,614 93,001 83,634
Hair care and skin care [Member]        
Segment Reporting Information [Line Items]        
Total net sales 472,302 476,864 1,308,356 1,022,458
Total segment gross profit 255,968 247,859 685,964 641,966
Consolidated total assets 4,647,830 4,232,913 4,647,830 4,232,913
Consolidated total payments for property and equipment and intangible assets 1,870 1,870
Consolidated total depreciation and amortization 932 1,417 2,610 4,251
Hearing enhancement and protection [Member]        
Segment Reporting Information [Line Items]        
Total net sales 6,450,065 5,992,479 19,197,857 19,974,831
Total segment gross profit 4,710,460 4,376,467 13,932,159 14,887,865
Consolidated total assets 8,303,317 8,480,805 8,303,317 8,480,805
Consolidated total payments for property and equipment and intangible assets 146,285 9,347 253,908 80,192
Consolidated total depreciation and amortization $ 44,734 $ 26,197 $ 90,391 $ 79,383
v3.25.1
Income Taxes (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
Income Tax Disclosure [Abstract]        
Income tax expense $ 53,085 $ (827,436) $ 120,335 $ (397,054)

Grafico Azioni AXIL Brands (AMEX:AXIL)
Storico
Da Mar 2025 a Apr 2025 Clicca qui per i Grafici di AXIL Brands
Grafico Azioni AXIL Brands (AMEX:AXIL)
Storico
Da Apr 2024 a Apr 2025 Clicca qui per i Grafici di AXIL Brands